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February 2019 
 
Abstract 
Haliotis midae aquaculture within South Africa remains afflicted by infectious diseases. Understanding of 
how the abalone’s innate immune response functions is one of the greatest hindrances to assisting with 
the defence or detection of pathogenic attacks on farms. The multifunctional oxygen transporter 
haemocyanin was previously found to be upregulated in response to bacterial infection (Beltran 2015), 
indicating it may play a role in the defence response of Haliotis midae. The current knowledge regarding 
haemocyanin’s role in the abalone innate immune response is incomplete. A number of studies have been 
published that investigated haemocyanin’s potential as a broad spectrum antimicrobial peptide in many 
arthropod species. There has been only one study conducted in molluscs, which utilised synthetic peptides 
derived from a haemocyanin consensus sequence. In most organisms the haemocyanin protein is 
comprised of a string of eight roughly 50 kDa functional units (FU) annotated a-h. The current study 
determined the nucleotide sequence of the final four functional units on the C-terminal end of H. midae 
haemocyanin and examined the potential antimicrobial activity of the peptide product. The haliotisin 
coding sequence identified by Zhuang et al. (2015) was detected in FU-e of the H. midae haemocyanin 
and subcloned into an Escherichia coli expression vector for recombinant production of the peptide. This 
peptide showed some activity against Staphylococcus aureus and E. coli, suggesting it may function as an 
antimicrobial peptide. This study provides the first evidence that an antimicrobial peptide derived from 
the H. midae haemocyanin could be functioning as a component of the abalone innate immune response.   
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1.1 Introduction 
Abalone are a commercially important marine species; the flesh from the large foot is consumed as a 
delicacy in east Asian regions, particularly in Japan and China, who import the most abalone globally (Mau 
& Jha 2018). The increase in the development of the abalone sector was also influenced by the 
development of a market for cocktail sized abalone. The market price for abalone fluctuates, depending 
on the quality and species produced, but is usually set around US$15–30/kg (Cook & Gordon 2010; Mau 
& Jha 2018). The largest suppliers of wild abalone are Australia, Japan, New Zealand, South Africa and the 
United States, while the largest producers of farmed abalone are China, Taiwan, South Africa, Australia 
and Chile (Mau & Jha 2018). South Africa is currently the fourth largest exporter of abalone globally  and 
the largest exporter of cultured abalone outside of Asia (Kilian 2016; Troell et al. 2006). South African 
abalone inhabit primarily the west coast region, due to the colder waters (Vosloo et al. 2013).  
During the 1970s, the South African abalone fishery sector was decommercialised because of its severe 
impact on the wild population. It was reopened in the early 2000s, but the annual catch allowance was 
severely reduced to 150 tonnes  (Cook 2014). This limitation was put in place because of a decline in the 
population due to over-exploitation, illegal harvesting, disease and habitat degradation. Illegal harvesting 
over the last few decades remains a major contributor to the declining wild abalone population. Poaching 
levels escalated in the 1990s, and by 2002 more abalone was being confiscated than legally exported. This 
highly organised criminal industry led to wild H. midae being brought to the edge of commercial extinction 
(Steinberg 2005).  
Farm-based production of abalone, however, increased dramatically over this time, with an almost-750% 
increase in farm production worldwide from 2002 to 2010 (Cook & Gordon 2010). Aquacultural practices 
have a high socioeconomic impact, providing employment, developing local farms and improving both 
domestic and international trade relations (Dixon et al. 2001). The shift away from commercial fishing 
towards an aquaculture-based practice not only produces a consistent, water-based food source but also 
relieves pressure on the wild population, allowing the wild abalone stocks to return to a healthy level. 
South African aquaculture-based abalone production is currently almost ten times greater than that of 
wild fisheries (Cook 2014; Department of Agriculture, Forestry and Fisheries 2016). The coastal waters of 
South Africa contain six different species of abalone, but Haliotis midae is the only species that is 
commercially exported, owing to its large size and relatively rapid growth rate (Sales & Peter J. Britz 2001).   
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1.1.1 Haliotis midae aquaculture 
Haliotis midae is the primary species of abalone found along the South African shoreline. Commonly 
referred to as perlemoen, it is a species of large sea snail belonging to the superfamily Haliotidae (Wood 
& Buxton 1996). Within the aquaculture sector, the export of H. midae is South Africa’s primary revenue 
source (Sales & Peter J Britz 2001; Raemaekers et al. 2011; M Troell et al. 2006; James 2018), and farming 
is South Africa’s dominant source of abalone for export. The drive towards aquaculture-based practices is 
in part due to the rapid decline of wild abalone populations caused by overfishing and poaching, as well 
as favourable local conditions, such as access to relatively cheap labour and electricity, good base 
infrastructure and good water quality. As of 2016, a total of 18 abalone aquaculture farms were 
operational in South Africa (Department of Agriculture, Forestry and Fisheries 2016), making it the second 
highest contributor in the marine aquaculture sector, with 1 479.22 tonnes produced per annum. The 
export of which created an estimated revenue of R460 million (Department of Agriculture, Forestry and 
Fisheries 2016). Twelve of the aquaculture facilities that produce abalone are land-based with 
independent hatcheries and four operate as grow-out facilities only, where no hatching takes place and 
juveniles are grown to maturity. The final two facilities make use of sea cage culture, where cages with 
stock are maintained offshore within the ocean. The primary contributor to crop loss within the abalone 
aquaculture industry on a global scale remains infectious diseases (Lafferty et al. 2015). 
1.1.2 Diseases affecting abalone aquaculture 
Disease outbreaks in aquacultured abalone remain the most significant cause of economic loss globally 
(Sindermann 1984; Cook 2014). South African aquaculture farms lie primarily along the coastal regions 
and are thus heavily reliant on coastal water inputs to maintain their stocks, so that farmed abalone are 
susceptible to the same environmental fluctuations that threaten the wild population. A good example of 
this is the spread of harmful algal blooms (HAB) which have been found to cross over from wild 
populations into farming practices. A bloom in 1989 caused a mortality of 40 tons of wild abalone on the 
southwest coast of South Africa (Horstman et al. 1991), and a more recent event in 2017 near Walker Bay 
is having similar effects (Pitcher et al. 2019). More frequent extreme-weather conditions due to climate 
change have resulted in alterations in the temperature, salinity, oxygen and carbon dioxide levels of 
coastal waters (Morash & Alter 2016). Changes in the marine environment have led to predictions that 
the global wild mollusc population will dramatically decline between 2020 and 2050 (FAO 2016). Highly 
intensive farming practices further contribute to the unstable conditions and include farm-specific 
stressors such as elevated ammonia levels, high stocking densities, handling of abalone and nutrition 
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(Morash & Alter 2016; Hooper et al. 2011). Ammonia arises as the primary form of nitrogenous waste 
produced by the abalone as a toxic waste product of amino acid metabolism (Spotte 1970). In the natural 
oceanic environment the ammonia concentrations rarely reach toxic levels, but in semi-enclosed densely 
populated aquaculture facilities, ammonia can easily reach levels that affect physiological functions and 
induce stress (Spotte 1970; Morash & Alter 2016). The current culture methods for abalone also require 
various steps in which organisms need to be dislodged from their rearing substratum for the purposes of 
size grading, adjusting densities, tagging or transferring from indoor to outdoor culture facilities (Chacon 
et al. 2003; Hooper et al. 2011). To this effect, the abalone are moved either with or without anaesthetics 
and both have been shown to induce stress in the organisms. An increase in stressors has been linked to 
an increased susceptibility to infections (Hooper et al. 2007; Hooper et al. 2014; Malham et al. 2003), 
indicating that the stressful factors that affect farmed abalone also result in the decreased immune 
response of said organisms.  
Pathogens that affect both wild and farmed abalone include bacteria, viruses, fungi and fungal-like 
pathogens, and protozoans (Bower et al. 1994; Paillard et al. 2004; Bondad-Reantaso et al. 2005; Macey 
et al. 2011), so combatting infections is not straightforward. The largest proportion of diseases within 
abalone is due to bacterial infection, with abalone mortality rates as high as 90% (Nicolas et al. 2002). For 
example, mass mortalities of the abalone species Haliotis tuberculata L. occurred on the French coast 
from 1997 into the early 2000s, the Vibrio species, identified as V. carchariae, spread from the south coast 
and along the west coast causing the death of between 60 and 80% of the abalone population. In 1999, 
this bacterium also affected a land-based farm in Normandy, where losses of up to 85% occurred. Other 
than sporadic instances of white pustules on the foot, there were no indications that the animals were 
afflicted prior to their death (Nicolas et al. 2002). Similarly, from the late 2000s, the bacteria Vibrio 
parahaemolyticus and Vibrio alginolyticus were the cause of mass mortalities in Taiwanese grow-out 
farms and settlement failure of spat larvae in nursery ponds (Bondad-Reantaso et al. 2005). Similar 
scenarios have played out in Japan, America, France, China and Australia (Lafferty et al. 2015; Lafferty & 
Kuris 1993; Mayfield et al. 2011; Sawabe et al. 2007; Nicolas et al. 2002). South Africa has faced similar 
issues: reports have been made of abalone infections by Vibrio and Clostridium bacteria, along with the 
occurrence of gut-associated parasites and the presence of paralytic, shellfish-poisoning toxins (Pitcher et 
al. 2001; Dixon et al. 1991; Mouton & Gummow 2011).  
The variable living conditions of aquacultured abalone are optimal for the spread of pathogens. Stressful 
environmental conditions such as a change in temperature, pH or oxygen levels leads to reduced immunity 
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and allows for easier infection, while the proximity of neighbouring abalone due to high tank stocking 
densities allows the pathogen to spread quickly through an entire stock. These conditions are optimal for 
the spread of species such as Pseudomonas, Aeromonas and Vibrio (Sindermann 1984). Vibriosis caused 
by Vibrio spp. remains one of the most prevalent diseases in fish and other aquaculture-reared organisms 
and is responsible for mass mortality in aquaculture systems worldwide (Haldar & Chatterjee 2012).  
Compounding these issues, pathogen transfer can occur between reared and wild populations of abalone 
(Arechavala-Lopez et al. 2013; Lafferty et al. 2015). As most land-based aquacultural systems are coastal, 
it is possible for one population to infect another, resulting in either major consequences for the wild 
population or major crop loss for farmed abalone. One prominent example of this would be the outbreak 
of abalone viral ganglioneuritis (AVG) in Australia. The disease spread from cultured abalone into the 
surrounding wild population resulting in mass mortalities (Corbeil et al. 2016).  Pathogens do not travel 
exclusively through water, however – wild kelp, readily available on the nearby coastline, is used as the 
primary feed in many land-based aquaculture facilities, and pathogens in wild abalone populations are 
introduced onto farms via kelp collected close by (Mouton & Gummow 2011).  
1.1.3 Health management on abalone farms 
Currently, the primary focus for abalone farmers is on the prevention of pathogenic attack rather than 
therapy post infection. Prevention is primarily achieved by administering antibiotics to the feed 
(Handlinger et al. 2005). However, through misuse and overuse of antibiotics, there is an emerging threat 
of antibiotic-resistant bacteria that could infect the abalone and be transferred to humans upon 
consumption, causing consumers to be afflicted with a strain of bacteria that is resistant to all current 
treatment methods (Lee et al. 2003b; Schwarz et al. 2001). Another method for disease prevention is to 
reduce stocking densities or to invest more heavily in ensuring that water quality and diet are of a high 
enough standard to reduce opportunistic pathogen attacks. However, these solutions come with a high 
economic weight. Recently, the use of probiotics has gained popularity as an alternative to antibiotics 
(Balcázar et al. 2006; Kesarcodi-Watson et al. 2008). In one example, this worked by stimulating the 
immune response of the abalone through exposure to non-pathogenic bacterial species (Balcázar et al. 
2006).  
Despite the preventive methods described above, outbreaks of disease continue to plague the abalone 
aquaculture industry. Currently, the best methods for assessing whether a general abalone infection exists 
is through in vitro testing of the count and quantity of the different morphologies of haemocytes, as well 
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as through phagocytic capability and respiratory burst assays (Hooper et al. 2007). There are other 
methods for testing for specific infections, such as PCR, real time PCR, hybridization and histology but 
these are all costly and are only worth conducting if you have already determined that an infection exists 
within the abalone. However, much of our understanding of the functioning of the abalone immune 
response originates indirectly through research performed on other invertebrate species (Hooper et al. 
2007; Song et al. 2003); the specifics of the abalone immune response needs investigation to confirm 
correlated functioning. A comprehensive exploration of the innate immune response of H. midae could 
provide insight into previously unknown molecular mechanisms of the abalone innate immune response. 
1.2 Invertebrate immune response  
The increased occurrence of infectious diseases in marine invertebrates emphasises the need to better 
understand how they cope with immunological challenges in both their natural habitats and in 
aquaculture (Terwilliger 2007). The term “invertebrate” is very broad and includes species making up 
around 95% of the animal kingdom split amongst 30 different phyla (May 1988).  The term “invertebrates” 
includes molluscs, like abalone, but also many other marine invertebrates, and the largest group within 
the arthropods, the insects. The challenges faced by species within the invertebrate phylum vary greatly 
depending on their ecological niche. Immunological strategies employed by one group are thus different 
from those employed by the next group. Even within the same group, members sometimes use vastly 
different strategies of internal defence (Loker et al. 2004), and generalisations regarding “invertebrate 
immunity” should therefore be avoided until confirmed in the organism of interest. Our current 
understanding of abalone innate immunity is based on a very limited set of research conducted with 
abalone, a broader range of research undertaken with other gastropods and bivalves, a large body of 
research on other invertebrates, while the bulk of the research is inferred from vertebrate innate immune 
systems (Hooper et al. 2007).  
Without a significant adaptive immune response, invertebrates are limited to their innate immune 
system. Lacking the “true” lymphocytes and functional antibodies found in vertebrates, the central dogma 
within evolutionary biology became that invertebrates rely entirely on their innate immunity (Rowley & 
Powell 2007). One possible explanation for how invertebrates survive without an adaptive immune 
system is that their innate defence systems are highly effective, while another is that there are more 
defences than are currently known (Loker et al. 2004). Lacking the complicated features that are required 
for an adaptive immune response, invertebrates are forced to employ other methods to generate diversity 
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and a complex response to attack (Hooper et al. 2007). The stages of the innate immune system begin 
with the first line of defence, which include physiochemical barriers such as the shell, skin and mucus 
layer. Following this, the cellular and humoral components are presented in a regulated manner to fight 
off infection (Girón-Pérez 2010).  
The first stage of internal defence is the critical recognition stage. Invertebrates have an immune-
neuroendocrine-recognising system that is capable of recognising self from non-self. This system is 
generally considered to be only slightly less complex than that found in its vertebrate counterpart 
(Ottaviani et al. 1998). The primary cell type used for recognition and cellular defence is the haemocytes, 
which can be divided roughly into two morphologies: hyalinocytes, which are smaller, with less cytoplasm 
and therefore fewer or no granules; and the granulocytes, larger cells with more cytoplasm 
accommodating a greater number of granules (Tiscar & Mosca 2004; Travers et al. 2008).  
Molluscs and arthropods possess an open circulatory system, where the heart distributes haemolymph 
into the body cavity in such a manner that the organ systems are bathed in it, allowing immune response 
cells ample opportunity for chance encounters with foreign elements (Bayne 1990). Haemocytes are the 
main defence molecule in molluscs and are capable of chemotaxis, antigen recognition, attachment 
followed by agglutination, phagocytosis and elimination of invaders by respiratory burst (Hooper et al. 
2007). The exact mechanisms for how these cells differentiate self from non-self and perform 
phagocytosis is not fully understood in the abalone system, but has been extensively characterised in 
other marine invertebrate species (Canesi et al. 2002; Canesi et al. 2006; Casas et al. 2011; Cardinaud et 
al. 2015).  
Phagocytosis acts as the first line of internal innate immune defence (Bayne 1990) and has a clearly 
defined sequence: recognition; chemotaxis; attachment; ingestion; and destruction of the invading 
pathogen. Once the pathogen has been engulfed, the vacuole within the cytoplasm is referred to as the 
phagosome. This fuses with the lysosome, which contains degradative enzymes, to form the 
phagolysosome, which destroys, degrades and eliminates the foreign material via either an oxygen-
dependant system (respiratory burst) or an oxygen-independent system (Bayne 1990; Hooper et al. 2007; 
Mogensen 2009). The cellular response during the innate immune response is complemented by the 
humoral response.  
The haemolymph of abalone and other organisms with an open circulatory system is responsible for the 
transport of nutrients, oxygen, hormones and cells throughout the body (Fredrick & Ravichandran 2012). 
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Thus, beyond transporting haemocytes to the site of pathogenic attack, the haemolymph and its 
molecular constituents also play a role in innate defence. Humoral defence factors include lectins, 
agglutinins, lysosomal enzymes and, most importantly, antimicrobial peptides (Casas et al. 2011; Nappi & 
Ottaviani 2000; Marmaras & Lampropoulou 2009; Koutsogiannaki & Kaloyianni 2010). Agglutinins and 
agglutinin-like molecules such as lectins are responsible for the targeting of foreign material for 
degradation, while lysosomal enzymes are responsible for hydrolysing microorganisms (Tiscar & Mosca 
2004). 
The prophenoloxidase (proPO) system is an important component of the humoral immune response of 
invertebrates and is directly involved in non-self-recognition and defence (Pang et al. 2014). The molecule 
prophenoloxidase and its corresponding activating enzymes are stored in haemocyte granules and 
released upon haemocyte stimulation (Hooper et al. 2007). The subsequent proPO cascade modulates the 
activation of phenoloxidase. Activated phenoloxidases, whose counterpart is tyrosinase in mammals 
(Adachi et al. 2005), is responsible for catalysis of the initial stages of the biosynthetic pathway that 
eventually results in the formation of the microbiocidal pigment, melanin (Coates & Nairn 2014). 
Phenonoxidases catalyse two reactions: the hydroxylation of monophenols to ο-diphenols and the 
oxidation of ο-diphenols to ο-quinones (Hooper et al. 2007). These reactions cause the production of 
reactive oxygen species (ROS) as by-products in the eventual formation of melanin (Coates & Nairn 2014; 
Söderhäll & Cerenius 1998). Melanisation is intimately associated with the appearance of factors that 
stimulate cellular defence by aiding the phagocytic and encapsulation processes (Cerenius et al. 2008). 
Antimicrobial peptides, or AMPs, can act systemically or provide localised protection against 
environmental pathogens. They display hydrophobic and cationic properties and usually have a molecular 
mass that is less than 30 kDa.  
1.2.1 Antimicrobial peptides 
Although antimicrobial peptides have been described as ancient evolutionary weapons, AMPs have 
remained effective as defensive molecules despite their ancient lineage (Zasloff 2002). They possess a 
broad ability to kill microbes. To date, over 1 200 AMPs with a broad spectrum of activity have been 
classified from Eukaryotes, providing effective protection against both Gram-negative and -positive 
bacteria, yeast, fungi and, in some cases, even viruses and protozoa (Ellis et al. 2011). All AMPs are derived 
from a larger precursor protein and require post-translational modifications, such as proteolytic cleavage 
and, in some cases, glycosylation, to become biologically active (Zasloff 2002). Recently, there has been 
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evidence of proteins undergoing partial hydrolysis to generate antimicrobial peptides  (Zhuang et al. 
2015).  The process of synthesising AMPs can take a few minutes or hours post-challenge (Fredrick & 
Ravichandran 2012).  
Large AMPs, with sequences that are longer than 100 amino acids, either function as lytic proteins, 
nutrient-binding proteins, or specifically target microbial macromolecules; small AMPs, on the other hand, 
act by disrupting structures or functions within the cell wall of invading pathogens (Fredrick & 
Ravichandran 2012). AMPs have such high sequence diversity that the same nucleotide sequence is rarely 
recovered from two species, even if they are closely related, but there is significant conservation of the 
antimicrobial peptide amino acid sequences (Zasloff 2002). Some shared characteristics include small size, 
a cationic character and the presence of 30–50% hydrophobic residues (Ellis et al. 2011). Different AMPs 
are broadly categorised based on their secondary structure. In general, the molecule will adopt a shape 
that clusters the hydrophobic and cationic amino acids spatially in a discrete manner, allowing for an 
amphipathic design (Zasloff 2002). Linear peptides, such as the African clawed frog’s magainin and the silk 
moth’s cecropin, only adopt this organisation when they enter the membrane (Steiner et al. 1981; Zosloff 
1988). A particular frog species belonging to the genus Rana modifies the design by adding a single loop 
formed via a disulphide bond at the carboxy end (Simmaco et al. 1998), whereas bacternecin and 
defensins possess a rigid anti-parallel β-sheet constrained by disulphide bonds as the framework (Romeo 
et al. 1988; Selsted et al. 1985). The diversity of AMPs probably reflects the species’ adaptation to the 
unique microbial environments that characterise the niche it occupies. To effectively eradicate infections, 
most multicellular organisms will use a cocktail of AMPs comprised of multiple peptides belonging to 
several structural classes (Zasloff 2002). 
Marine invertebrate research into the expression and action of AMPs has been focussed on bivalve 
molluscs and crustaceans (Ellis et al. 2011). From studies it has been found that different groups of AMPs 
display different antimicrobial activities and modes of action. They belong to one of three major groups: 
peptides with an α-helical shape; cyclic and open-ended cyclic peptides with pairs of cysteine residues; or 
peptides with an over-representation of some specified amino acids (Bulet et al. 2004; Dimarcq et al. 
1998), and some peptides that don’t fit any of these categories. 
The membrane of bacterial cells is organised in such a way that the outer membrane is populated with 
negatively charged phospholipid headgroups (Zasloff 2002). This contrasts with animal cell membranes, 
which are mainly composed of the more neutrally charged phospholipids. As AMPs generally have a low 
14 | P a g e  
 
hydrophobicity, they will have a lower affinity for the self-cells and be more attracted to the invasive cells 
(Matsuzaki 2001). 
With their amino acid composition, amphipathicity, cationic charge and small size, antimicrobial peptides 
are well suited to attach to and insert into bacterial membrane bilayers. In so doing, they form pores by 
one of three hypothesised methods: “barrel-stave”, whereby the peptide helices form a bundle in the 
membrane with a central channel; “carpet model”, whereby the peptides accumulate on the bilayer 
surface and force pieces of the membrane to be removed; and the “toroidal-pore model”, whereby 
peptide helices insert into the membrane and cause the lipid monolayers to bend continuously through 
the pore so that the water core is lined by both the inserted peptides and the lipid head groups (Brogden 
2005). These are illustrated in Figure 1.1, adapted from the review by Brogden (2005).  
 
Figure 1.1: Antimicrobial peptides induce killing by creating pores in the bacterial membrane. 
Hydrophilic regions are shown in red and hydrophobic regions are blue. A. The barrel-stave 
model: Aggregated peptides insert into the membrane bilayer and orientate so that the 
hydrophobic portion of the peptide aligns with the lipid core region and the hydrophilic side 
forms the inside of the pore. B. The carpet model: The peptide orientates parallel to the 
surface of the lipid bilayer and forms an extensive layer or carpet. C. The toroidal model: The 
attached peptides aggregate and cause the lipid monolayers to bend continuously through 
the pore. Figure adapted from Brogden (2005). 
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Once a pore is created, the AMP kills the bacterial cell via one of the following proposed methods: fatal 
depolarisation of the normally energised bacterial membrane (Westerhoff et al. 1989); creation of 
physical holes that cause cellular contents to leak out (Yang et al. 2000); activation of deadly processes, 
such as induction of hydrolases, that degrade the cell wall (Bierbaum & Sahl 1985); or scrambling of the 
usual distribution of lipids between the leaflets of the bilayer, resulting in the disturbance of membrane 
functions (Matsuzaki 2001). Furthermore, there has been recent speculation that transmembrane pore 
formation may not be the only way in which antimicrobials function (Brogden 2005). The peptides may 
also damage critical targets after internalisation (Kragol et al. 2001) in that translocated peptides can alter 
formation of the cytoplasmic membrane septum, inhibit cell wall synthesis, inhibit nucleic acid synthesis, 
inhibit protein synthesis or inhibit the enzymatic activity of proteins (Brogden 2005).  
1.3 Haemocyanin 
The haemocyanin polypeptide sequence is the largest obtained to date for any respiratory protein (Harris 
et al. 2000; Lieb et al. 2000). Haemocyanin is one of the primary proteins in the haemolymph of the 
abalone’s open circulatory system. The blue respiratory protein, present in the haemolymph of many 
molluscs and arthropods, possesses a copper type-3 centre that reversibly binds to oxygen molecules 
(Markl 2013; Van Holde et al. 2001). Recent studies suggest that this large, multimeric protein may have 
additional immune response attributes. Work done by the Marine Biotechnology laboratory in the 
Molecular and Cell Biology Department at the University of Cape Town found, through a proteomics-
based study, that the haemocyanin present in the South African abalone H. midae was upregulated in 
response to bacterial infection (Beltran 2015). Before understanding how this protein may function during 
an immune response, it is necessary to discuss what makes the structure and evolution of this protein 
unique. 
1.3.1 Structure 
Typically, the structure of molluscan haemocyanin protein is a string of eight roughly 50 kDa functional 
units (FU) annotated a–h. This is reflected by its gene structure, which has eight structurally related coding 
regions, each separated by a variable linker region (intron) (Lieb et al. 2001). Haliotis tuberculata 
haemocyanin 1 has a high degree of similarity between respective functional units (around 45% similarity 
on the protein level). Corresponding functional units within Octopus dofleini share around 55% identity 
with the H. tuberculata haemocyanin at the protein level. This structural layout can be seen in Figure 1.2, 
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which shows the gene structures for the Haliotis and Octopus haemocyanin. The only relevant difference 
between the two is that the Octopus sequence lacks the C-terminal functional unit of its Haliotis 
counterpart (Lieb et al. 2001). For the most part, each of the functional units are encoded by a single 
unbroken exon, except for functional units a, f and g, which contain four, two and three exons 
respectively. These broken exons are separated by what is referred to as internal introns.  
The internal and linker introns are strikingly different: the linker introns are very regular and have 
remained in the same position and phase since the evolution of the multiunit protein (Lieb et al. 2000; 
Altenhein et al. 2002), whereas the internal introns, by contrast, are far more scattered in their position 
and phase. The term “Phase” in this instance refers to which nucleotide in the codon the intron appears 
in. This organisation can be explained by a genetic mechanism that must have been used to generate the 
multiunit structure from a monomeric precursor (Lieb et al. 2001).  
1.3.2 Oxygen transport 
Haemocyanins are extracellular oxygen-transporting metalloproteins, and each of the functional units are 
able to reversibly bind to a dioxygen molecule via their binuclear copper sites (Lieb & Markl 2004) (Figure 
1.3). Each of these copper atoms is liganded to three histidine residues to form both the copper A and 
copper B sites (Lieb et al. 2001). The copper B site is the only region that shows similarity between 
molluscan and arthropod haemocyanin sequences, the limited similarity suggesting that these two phyla 
evolved independently (Lieb et al. 2001). The other site (A site) of abalone haemocyanin has a closer 
resemblance to that found in tyrosinases. It is likely that the tyrosinases and molluscan haemocyanin 
evolved from a common polypeptide chain that contained both the copper A and copper B sites (Lieb et 
al. 2001).  
 
Figure 1.2: The gene structure of HtH1 (Haliotis) and OdH1 (Octopus). Each of the Functional Units (a-h) are 
indicated by a separate colour. Introns (grey for the linkers and black for internal) are shown to scale. utr indicates 
the 3’ untranslated region. S1 and S2 correspond to the two exons encoding each signal sequence. Figure taken 
from Lieb et al. (2001). 
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Due to conversion of copper from the CU(I) state (deoxy form) to the oxygenated CU(II) state (Van Holde 
et al. 2001), a colour change from colourless to blue is evident in haemocyanin once an oxygen molecule 
is bound (Miller et al. 1998). A single haemocyanin polypeptide can carry as few as six oxygen molecules 
or as many as several hundred (Lieb et al. 2001).  
1.3.3 Assembly of haemocyanin 
In molluscs, each of the eight functional units has two well-defined domains. The α-helical domain, which 
includes the oxygen binding site, is connected by a hinge to a β-sandwich domain that is rich in β-sheets 
(Lieb et al. 2001) (Figure 1.4). Most organisms contain two separate isoforms of the haemocyanin protein, 
which can be differentiated either at the genetic level or by their formation of multidecameric proteins 
(Keller et al. 1999). For Haliotis tuberculata, these two isoforms are named Haliotis tuberculata 
haemocyanin 1 (HtH1) and Haliotis tuberculata haemocyanin 2 (HtH2). They share 66% similarity to one 
another and are thus distinguishable at the gene level (Altenhein et al. 2002).  
One translated gene of the eight functional units makes up a single subunit of the final multimeric protein. 
Ten of these subunits arrange themselves together in order to form a decamer (Altenhein et al. 2002) 
 
Figure 1.3: Structure of the molluscan haemocyanin subunit. A Active site with the two copper ions, six histidine 
residues and one bound dioxygen molecule (red). B A ribbon representation of a functional unit with the atoms 
of the single active site highlighted as spheres. Figure taken from Markl (2013) 
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(Figure 1.4). The first isoform (HtH1) is found predominantly in this decameric form and the second 
isoform is found predominantly as a didecamer, formed via face-to-face assembly of two decamers.  
The assembled ring-like decamer consists of a wall of 60 globular functional units and a collar complex 
with the remaining 20 functional units. The first six functional units (FU-a–f) of a single subunit are 
generally considered to form the cylinder wall, while the rest form the collar (Markl 2013). The final 
functional unit (FU-h) contains a cupredoxin-like domain. This decameric molecule, which ends up being 
4 MDa in size, has a diameter of 356 nm in its cylinder wall and 18 nm in height (Keller et al. 1999).  
Haemocyanins are classified as glycoproteins, indicating that they are able to undergo glycosylation (Keller 
et al. 1999). The HtH1 protein contains 13 potential N-glycosylation sites, while HtH2 contains 11. It was 
further determined that the carbohydrate content of molluscan haemocyanins is unusually high (2–9% 
w/w) and that they also contain unusual monosaccharides (Kostadinova et al. 2013). While it is uncertain 
 
Figure 1.4: Structural representations of arthropod and molluscan haemocyanins. Figure taken from Decker 
(2007). 
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whether all the glycosylation sites present are glycosylated at all times, these sites have been determined 
to play an important role in how haemocyanin functions within the innate immune response.  
Recently, there has been a greater emphasis on haemocyanin function beyond its role in the 
transportation of oxygen, leading to several studies proposing that it may play a role in the innate immune 
system of invertebrates (Decker et al. 2007; Hristova et al. 2008; Dang et al. 2011; Beltran 2015; Zhuang 
et al. 2015). Due to the fact that invertebrates lack an adaptive immune response and therefore are 
necessitated to adapt the functioning of the proteins available to them, haemocyanin, with its unusually 
large size, provides a likely candidate for a component of the invertebrate innate immune response.  
1.3.4 Role of haemocyanin in the immune response 
In addition to its main function as an oxygen transporter, haemocyanins also appear to exhibit protective 
properties against bacterial, fungal and viral infections (Dolashka & Voelter 2013). Haemocyanins have 
recently been shown to act as phenoloxidases (POs) and are processed to become active antimicrobial 
peptides (AMPs). In arthropods, the phenoloxidases and haemocyanins appear to be closely related, while 
in Mollusca the haemocyanins are more closely related to tyrosinases of other phyla (Cerenius et al. 2008). 
Phylogenetic analysis of haemocyanin, phenoloxidase and other members of this gene family is consistent 
with both their phenoloxidase and oxygen-binding properties.  
1.3.4.1 Haemocyanin as a phenoloxidase 
Under certain conditions, haemocyanin has been shown to act as a phenoloxidase and therefore it is likely 
to participate in the immune response (Terwilliger 2007). It is possible that some haemocyanin proteins 
have their function transformed from oxygen transport to phenoloxidase activity only in response to 
major bacterial invasion. The melanisation pathway, under the control of phenoloxidase, has many 
precursor molecules, and therefore, has multiple stages that can be assayed for activity. Molecules like 
5,6-dihydroxindole (DHI) and 5,6-dihydroxindole-2-carboxyllic acid (DHICA) function as precursors of 
eumelanin, which is a product of the melanisation pathway (Adachi et al. 2005). Polymers of the 
haemocyanin subunits isolated from Marsupenaeus japonicus haemolymph were capable of converting 
DHI into a black pigment, which indicates a phenoloxidase-like activity. The arthropod haemocyanin was 
also inhibited by inclusion of tyrosinase and phenoloxidase inhibitors in the assay. This indicates that the 
mechanisms employed by tyrosinases and phenoloxidases are similar to that utilised by haemocyanin and 
that both proteins are important in the conversion of DHI in the haemolymph, a necessary step in the 
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melanisation pathway (Adachi et al. 2005). Phenylthiourea inhibition of haemocyanin confirmed that 
copper plays a key role in the reaction.  
Diphenoloxidase activity was also investigated in haemocyanin isolated from Rapana venosa haemolymph 
(Hristova et al. 2008). Under normal conditions, haemocyanin transported dioxygen molecules, whereas 
one of the oxygen molecules was used to facilitate chemical transformations during a severe bacterial 
infection. Using ο-diphenol and L-Dopa as substrates, Hristova et al. (2008) demonstrated that 
haemocyanin had similar oxidation capabilities to that of phenoloxidases or tyrosinases, but that 
haemocyanin required proteolytic cleavage of either the N- or C-terminal end to disrupt the protein 
structure. This cleavage opens a large entrance to the active site, allowing access to phenolic substances. 
In molluscs, the C-terminal end of the peptide is removed, while in arthropods it is the N-terminal end 
(Hristova et al. 2008).  
1.3.4.2 Haemocyanin as an antiviral 
Haemocyanin has been shown to have antiviral capabilities. Using a two-dimensional gel electrophoresis 
(2-DGE) proteomic analysis, Dolashka et al. (2013) showed that, in response to viral arthropod infections, 
several haemocyte proteins, including haemocyanin, increased post-infection. As haemocyanin is a 
glycoprotein, it was hypothesised that the carbohydrate chains were interacting with surface-exposed 
amino acids or other carbohydrate residues on the virus through Van der Waals interactions. It was also 
discovered that molluscan haemocyanin functional units with specific glycosylation patterns possessed 
antiviral activity (Dolashka & Voelter 2013; Kostadinova et al. 2013).  
Haemocyanin-derived peptides isolated from shrimp possessed properties of a non-specific antiviral 
nature that affected a range of cultured DNA and RNA fish viruses, while maintaining no cytotoxicity 
towards the host. The peptides were able to neutralise viruses and prevent viral replication (Zhang et al. 
2004). Abalone haemocyanin was also shown to have a unique mechanism of antiviral protection against 
Herpes simplex virus 1 (HSV 1) infections (Zanjani et al. 2016). Through the use of in vitro assays, Zanjani 
(2016) was able to demonstrate that the purified haemocyanin from H. rubra had a dose-dependent, 
inhibitory effect against HSV-1 infection. The protein specifically inhibited attachment and entry by 
binding to the viral surface through the glycoproteins gD, gB and gC present on HSV-1, most likely by 
mimicking their receptors. Post entry, however, haemocyanin had no effect.  
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1.3.4.3 Haemocyanin as an antifungal 
Haemocyanin has been observed to function as a precursor of antimicrobial and antifungal peptides 
(Coates & Nairn 2014). In response to fungal infections, the shrimp Penaeus vannamei and Penaeus 
stylirostris were found to have a higher concentration of the C-terminal end of haemocyanin 
(Destoumieux-Garzón et al. 2001), suggesting that this multifunctional polypeptide may play a role in 
protection against fungal infection. However, the mechanism of how this might be achieved has not yet 
been determined.  
1.3.4.4 Haemocyanin as an antimicrobial peptide 
Several haemocyanin-derived antimicrobial peptides have been discovered to date. The AMP Asticidin 1, 
a 16-amino-acid peptide isolated from the haemolymph of the crayfish Pacifastacus leniusculus, was 
found to have high bactericidal activity (Lee et al. 2003a). Lee (2003a) concluded that the peptide was 
derived from the C-terminal end of the crayfish haemocyanin and adopted a β-sheet conformation. The 
concentration of this peptide within the haemolymph increased greatly in response to microbial ligands. 
The release of astacidin 1 suggests the involvement of a lysosomal-derived, cysteine-rich protease that 
acts to cleave the AMP from crayfish haemocyanin. A further haemocyanin-derived AMP was isolated 
from haemolymph of the spider Acanthoscurria rondoniae. Termed rondonin, this peptide shared a high 
sequence homology to the C-terminus of several spider haemocyanin subunits (Riciluca et al. 2012). 
Additionally, two recombinant AMPs were designed to mimic the shrimp C-terminus of haemocyanin. 
Both of these peptides showed broad antifungal and antibacterial properties (Qiu et al. 2014). 
1.3.5 Haliotisin 
While the multifunctionality of haemocyanin as an AMP has been researched quite extensively in 
arthropods, few studies have been undertaken in molluscs, specifically abalone. One example of Haliotis-
specific research was conducted by Zhuang et al. (2015), who identified a candidate antimicrobial peptide 
derived from the H. tuberculata haemocyanin sequence. This putative AMP region, which was termed 
haliotisin, is located in the linker region between the α-helical and β-sheet domains of the haemocyanin 
FU-e (Zhuang et al. 2015). Comparing this region to the Antimicrobial Peptide Database (Wang et al. 2009), 
the authors of the study determined that haliotisin could have antimicrobial properties. The haliotisin 
region was found to have high sequence similarity to the same region in haemocyanins from several 
Haliotis species. Zhuang et al. (2015) designed eight overlapping synthetic peptides that spanned the 
haliotisin region (Figure 1.5) and incubated each peptide with bacteria to determine whether haliotisin 
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exhibited antimicrobial activity. Growth of the Gram-positive bacterium Bacillus subtilis and the 
Gram-negative bacterium Erwinia carotovora was significantly inhibited depending on the synthetic 
peptide used in the assay.  
Peptide 3 (P3) exhibited the strongest anti-proliferation activity when incubated with B. subtilis. The 
minimum inhibitory concentration (MIC) for this interaction was calculated to be between 0.3 and 1 μM. 
Peptide 6 (P6) also showed activity against B. subtilis but was only half as effective as P3, which was 
attributed to P6’s lack of the N-terminal amino acids present in P3 (Figure 1.5) and indicated that the N-
terminal portion of P3 may interact with an epitope that is present on the membrane of B. subtilis. 
Peptides 1, 2, 4, 5 and 6 (P1, P2, P4, P5 and P6) all exhibited antimicrobial activity towards E. carotovora. 
P6 was the only synthetic peptide able to inhibit the growth of both Gram-positive and -negative bacteria. 
It was suspected that this was due to the inclusion of both P3 and P4 as shown in Figure 1.5 (Zhuang et al. 
2015).  
Transmission electron microscopy (TEM) of E. carotovora incubated with P4 and B. subtilis incubated with 
P3 showed morphological abnormalities, including fragmentation of the pilli, a reduced number of flagella 
and the appearance of blisters on the surface of the bacterium. E. carotovora incubated with the P4 
synthetic peptide also showed damage and irregularities in the cell wall when compared to cells incubated 
without the peptide (Zhuang et al. 2015). 
The bold section in Figure 1.5 highlights one continuous peptide identified by Zhuang et al. (2015). This 
continuous peptide, which includes P3-P4-P5, seemed to exhibit the strongest antimicrobial activity. As a 
peptide, it has 29% hydrophobicity and is 6.75 kDa in size, indicating its potential as an AMP as it is small 
in size and consists of a high percentage of hydrophobic residues. While P3 and P4 both traverse the 
internal wall of the haemocyanin cylinder, a portion of the haliotisin peptide is located at the external 
 
Figure 1.5: Full amino acid sequence of haliotisin from H. tuberculata, showing the location of each of the 
overlapping synthetic peptides tested by Zhuang et al. (2015). The bold region is the section found to be the 
most biologically active. Figure adapted from Zhuang et al. (2015).  
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portion of the protein, allowing proteases access to potential cleavage sites that immediately follow P3-
P4-P5, and thus provide a possible method of peptide release from the greater haemocyanin protein. 
Serine proteases such as trypsin, chymotrypsin and proteinase K were identified as potential effectors 
(Zhuang et al. 2015). This study was the first to show that molluscan haemocyanin may act as a source of 
anti-infection peptides.  
1.4 Objectives of this study 
Haliotis midae cultivation is a valuable sector of the South African aquaculture industry, as attested to by 
South Africa’s status as the largest producer of commercial abalone outside of Asia (Troell et al. 2006). 
However, the industry suffers from significant financial losses as a result of regular outbreaks of pathogens 
and disease. Detection, prediction and management of such outbreaks requires a better understanding 
of how the abalone innate immune response operates. A large body of work has already been dedicated 
to characterising and decoding the innate immune response of other marine organisms and growing 
evidence suggests a high level of species-specific regulatory mechanisms, even within the same order 
(Hooper et al. 2007; Ghosh et al. 2011). The bulk of knowledge surrounding the abalone immune response 
has been generated from genomic (Wang et al. 2013; Travers et al. 2010), transcriptomic (De Zoysa et al. 
2011a; De Zoysa et al. 2011b) and a few proteomic studies (Slattery et al. 2012; Beltran 2015).  
Recently, through a proteomics-based study, it was found that haemocyanin, the oxygen transporter 
present in the haemolymph of H. midae, was upregulated in response to bacterial infection (Beltran 2015), 
suggesting that it could play a role in the abalone’s innate immune response. The haemocyanin protein, 
integral to the transportation of oxygen throughout the abalone, has been reported to play a part in both 
the cellular and humoral response of the invertebrate innate immune response. Some mechanisms 
described in section 1.3.4 are: functioning as a phenoloxidase in the melanisation pathway (Adachi et al. 
2005; Hristova et al. 2008; Coates & Nairn 2014); acting as an antiviral agent after glycosylation (Zhang et 
al. 2004; Zanjani et al. 2016); acting as an antifungal agent (Coates & Nairn 2014; Destoumieux-Garzón et 
al. 2001); and, most importantly for this study, acting as an antimicrobial peptide (Lee et al. 2003a; Riciluca 
et al. 2012; Qiu et al. 2014). These studies, largely investigating non-Haliotis invertebrates, imply that 
haemocyanin is a worthy candidate for further study regarding its possible role in the H. midae immune 
system. Further confirmation that haemocyanin can function as an AMP was reported by Zhuang et al. 
(2015) who identified the haliotisin peptide in H. tuberculata and demonstrated its antimicrobial activity 
against both Gram-positive and -negative bacteria. 
24 | P a g e  
 
This study aims to investigate a possible antimicrobial peptide derived from H. midae haemocyanin, and 
to this end, has three primary objectives. The first is to determine the sequence of H. midae haemocyanin 
in order to examine the structure of the protein and compare its similarity to other haemocyanin 
sequences and antimicrobial peptide sequences in order to locate a region that is similar to known 
antimicrobial peptides (the most likely candidate being the haliotisin peptide found by Zhuang et al. 
(2015)) for further investigation. The second objective of the study is to express the H. midae antimicrobial 
peptide using an Escherichia coli expression system to obtain sufficient quantities of the protein that 
would allow investigation of its potential antimicrobial activity. Thus, the final objective is to test the 
expressed H. midae haemocyanin peptide for antimicrobial activity. These objectives would provide 
information regarding the possible role of haemocyanin in the H. midae immune response.  
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2. Methods 
2.1.1 Abalone storage conditions 
H. midae used in this study were stored at the Department of Agriculture, Forestry and Fisheries Research 
Aquarium in Sea Point, Cape Town, South Africa. Abalone were kept in meshed baskets suspended in 
polyethylene tanks.  Baskets were kept at a stocking density of roughly 30 abalone per basket. The tanks 
were maintained in the dark with circulating filtered seawater taken from the nearby ocean, and constant 
aeration. Abalone were fed a diet of Ecklonia maxima fronds twice weekly for the duration of the project, 
and the tanks were thoroughly cleaned at least once a week.  
2.1.2 Haemolymph extraction and haemocyte counting 
Haemolymph was extracted from abalone with a shell length of 10 cm or greater. Using a sterile 21-gauge 
needle and 1 ml syringe, haemolymph was extracted from the pedal sinus of an individual abalone. A 10 μl 
aliquot was added to nine parts anticoagulant Alsever’s solution for haemocyte counting (0.1 M glucose 
(C6H12O6), 0.3 M trisodium citrate (C6H5Na3O7.2H2O), 0.5 M EDTA, 2.2% (w/v) sodium chloride (NaCl), 4.4% 
(w/v) formaldehyde (HCHO), pH7.5). Cell titre was determine using a haemocytometer and the relevant 
number of haemocyte cells were pelleted via centrifugation as needed for RNA or DNA extraction 
(described in 2.1.3 and 2.1.4).  
2.1.3 RNA extraction and cDNA synthesis 
RNA was extracted from between 3 and 4 million haemocyte cells using the RNeasy Mini Kit (QIAGEN) as 
per the manufacturer’s instructions, with the following minor modifications: cells were pelleted by 
centrifugation at 300 x g for 5 minutes and the supernatant removed and discarded; to ensure thorough 
cell lysis, the haemocyte suspension was vortexed for 30 minutes at 4°C, and subsequent centrifugation 
steps were conducted at 10 500 x g; an additional wash step with the provided buffer was added and an 
additional centrifugation step was included to elute residual ethanol; finally, the RNA was eluted from the 
column using 35 μl of RNase-free distilled water. The concentration of RNA was determined using a 
NanoDrop ND-100 spectrophotometer (NanoDrop Technologies, Inc.), and a 500 ng sample was run on a 
MOPS/formaldehyde agarose gel to check the integrity of the RNA. The QuantiNova™ Reverse 
Transcription Kit (QIAGEN) was used for cDNA synthesis from 500 ng of haemocyte RNA according to the 
manufacturer’s instructions, and haemocyte cDNA was either stored on ice and used immediately for PCR 
amplification or stored frozen at -80°C for not longer than a week.  
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2.1.4 Genomic DNA (gDNA) extraction 
DNA extraction was performed using a DNeasy® Blood and Tissue kit (QIAGEN) as per the manufacturer’s 
protocol. Between 5 and 6 million haemocyte cells were pelleted by centrifugation at 300 x g for 5 minutes 
and then resuspended in 200 μl of phosphate-buffered saline (PBS) supplemented with 20 μl of the 
provided proteinase K. From here, no alterations were made to the protocol and all solutions used were 
obtained with the kit. The concentration of DNA was determined using a NanoDrop ND-100 
spectrophotometer (NanoDrop Technologies, Inc). Genomic DNA was stored at -80°C until needed for PCR 
amplifications.   
2.2 PCR amplification and nucleotide sequence analysis 
Polymerase chain reaction (PCR) was used to amplify fragments of the haemocyanin gene from either 
haemocyte gDNA or cDNA, prepared as described in sections 2.1.3 and 2.1.4. The purpose of the PCR was 
to obtain fragments that could either be used as sequencing templates or for subcloning into the pProEX 
expression vector as described in section 2.3.  
2.2.1 Primer design 
Due to the unusually large size of the haemocyanin gene, a technique known as primer walking was 
employed to design the sequencing primers required for this study. The polymerase used was GoTaq® 
DNA polymerase (Promega) and, due to its efficacy, the amplicon size was limited to a max of 1 kbp. 
Figure 2.1 illustrates the primer-walking strategy, while the primers used in the study are shown in 
Table 2.1.  
 
Figure 2.1: Diagram illustrating the primer walking strategy used for amplification and sequencing the functional 
units e, f, g and h of the H. midae haemocyanin. Solid bars represent sequence data, arrows represent regions of 
primer binding and the template sequence to which the primers were designed.  
FU-d FU-e FU-f FU-g FU-h
Key
H. rubra haemocyanin sequence (GenBank: KU496942.1)
H. midae haemocyanin partial sequence (Franchiniet al. 2011)
H. midae haemocyanin FU-h sequence
H. midae haemocyanin FU-g sequence
H. midae haemocyanin FU-f sequence
H. midae haemocyanin FU-e/FU-f exon-exon boundary
H. midae haemocyanin FU-e sequence
Primer Pair for FU-h
Primer Pair for FU-g
Primer Pair for FU-f
Primer Pair exon-exon boundary FU-e/FU-f
Primer Pair for FU-e
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To start, annotated sequencing data was obtained from a study conducted at Stellenbosch University on 
Haliotis midae (Franchini et al. 2011). This contained a partial sequence for haemocyanin which served as 
the initial point for primer design. Using this sequence, a BLASTn search was performed to determine 
which fully sequenced Haliotis haemocyanin showed the highest similarity to that obtained for H. midae. 
Haliotis rubra, the Australian blacklip abalone, was found to have the highest sequence similarity to the 
partial segment of H. midae haemocyanin. Primers were designed using CLC (Main Workbench) v7.7 
(QIAGEN). For the initial PCR product, the reverse primer was designed against the H. midae sequence, 
and its complimentary forward primer was designed against the H. rubra haemocyanin sequence. These 
primers produced the first PCR product (green) in Figure 2.1. Once this had been amplified and sequenced 
(section 2.2.2), the sequencing data was used for designing the next primer pair. The reverse primer was 
designed using the H. midae sequence data, and the corresponding forward primer was designed using 
the H. rubra haemocyanin sequence. These primers produced the second PCR product (red) (Figure 2.1). 
This method was repeated a further three times to obtain and sequence the third (purple), fourth (blue) 
and fifth (orange) PCR products shown in Figure 2.1. All possible primer pairs were analysed using Primer 
BLAST (Altschul et al. 1990) and PerlPrimer (v1.1.21; Marshall 2004) to ensure that no secondary 
structures would be generated and that there was no cross- and self-complementarity. In this manner, 
primer pairs were designed to sequence the final four functional units (FU- e-h) of the H. midae 
haemocyanin.  
Table 2.1: PCR primers used to determine the nucleotide sequence of the carboxyl end of the H. midae haemocyanin 
gene. 
Name of primer Sequence 
H. midae FU-h Fwd TTGACTTCCTCTCCCTGC 
H. midae FU-h Rev CATTTCCTTCTCACCTCCCA 
H. midae FU-g Fwd CCCCCTTTACTGTTGTCATTCT 
H. midae FU-g Rev ACTACTGCCTTTACCCATCT 
H. midae FU-f Fwd TCTTTGCTGGTTTCCTGTTGT 
H. midae FU-f Rev GGCTGTGAAGTCGAGAGT 
H. midae FU-e/FU-f intron Fwd CCAGCAAAGACTCTAGCA 
H. midae FU-e/FU-f intron Rev TCTCCACGATATGCACCT 
H. midae FU-e Fwd TTGAGTCCTAGGGAGAGGGT 
H. midae FU-e Rev AGGTGCATATCGTGGAGAGT 
28 | P a g e  
 
 
2.2.2 PCR amplification and DNA sequencing 
The template selected for each PCR amplification was dependent on whether the amplicon was expected 
to contain an intron or not. Although genomic DNA was preferentially used as the template whenever 
possible, cDNA was employed in the majority of cases due to the presence of either internal introns or 
because the product spanned a linker intron between two functional units.  
After amplification, the PCR product was confirmed by electrophoresis through a 1.5% (w/v) agarose gel 
in TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA) at a pH of 8.3. The amplified product was 
purified using the Wizard® SV Gel and PCR Clean-Up Kit (PROMEGA) according to the manufacturer’s 
instructions and sent for sequencing (Macrogen Europe). Sequence data was analysed on CLC Main 
Workbench v7.7 (QIAGEN), trimmed, and the forward and reverse sequencing data aligned to one 
another. The sequence was searched against the NCBI database using the BLASTn search algorithm to 
confirm the identity of the gene.  
2.2.3 Comparison of haemocyanin sequence to antimicrobial peptides 
After sequencing the C-terminal half of the haemocyanin gene, focus shifted to analysing the region for 
homology to other Haliotis haemocyanin sequences and to determining whether a putative antimicrobial 
peptide could be identified within the sequenced functional units. The collected sequences were split into 
their respective functional units and each functional unit was then searched against the antimicrobial 
peptide database (Wang et al. 2009) (http://aps.unmc.edu/AP/main.php). The APD3: Antimicrobial 
Peptide Calculator and Predictor function was used to determine whether or which of the functional units 
that had been sequenced included a potential antimicrobial peptide. The returned region was then 
analysed for factors that affect antimicrobial peptide functioning, such as the presence of small, 
amphipathic molecules with a high proportion of hydrophobic residues (Papagianni 2003) and a secondary 
structure that usually follows either an alpha-helical shape or a β-sheet (Dhople et al. 2006).  
Once determined to be a potential antimicrobial peptide, the 3D structure of the amino acid sequence 
was predicted using the PHYRE2 engine (Kelley et al. 2015) and the output visualized and annotated using 
Chimera (Pettersen et al. 2004). The amphipathic nature of the molecule was examined using NetWheels 
(Mól et al. 2018), an online platform that assigns polarity to amino acid residues to visualize the α-helix in 
a way that shows the presence of polar and non-polar fronts.  
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2.3 Cloning into the vector pProEX and recombinant expression 
An H. midae haemocyanin gene fragment, predicted to code for a putative antimicrobial peptide, was PCR 
amplified from genomic DNA and cloned into the expression vector pProEX (Figure 2.2). pProEX was 
chosen as it adds a polyhistidine-tag to the N-terminal end of the peptide for purification purposes, along 
with the trc promoter, which allows inducible control over the expression of the recombinant product.  
2.3.1 Cloning of a putative antimicrobial peptide gene into the pProEX expression vector 
PCR primers were designed to amplify the region of the H. midae haemocyanin gene that potentially 
coded for a putative antimicrobial peptide. These primers included restriction sites required for 
subcloning: NcoI on the forward primer and NotI on the reverse primer. The forward primer was 
designated H. midae haliotisin cloning Fwd (GCGCCCATGGAGCCTGAGGACACTTTTG) and the reverse 
primer H. midae haliotisin cloning Rev (CATAGCGGCCGCCACAGTTGCGGAAGTACC) (Table2.2). The PCR 
products were digested with NcoI-HF® (Bio-Labs) and NotI-HF® (Bio-Labs) for insertion into pProEX (Figure 
2.2) to allow for transcription from the trc promoter. The produced mRNA could then be translated to 
form the recombinant haliotisin peptide with the 6-his tag included on the N-terminal end.  
Table 2.2: PCR primers used for cloning and sequencing of Haliotisin into pProEX 
Name of cloning PCR primer  Sequence of primer 
H. midae haliotisin cloning Fwd (NcoI) GCGCCCATGGAGCCTGAGGACACTTTTG 
H. midae haliotisin cloning Rev (NotI) CATAGCGGCCGCCACAGTTGCGGAAGTACC 
pProEX sequencing Fwd (M13Rev) GAGCGGATAACAATTTCACACAGG 
pProEX sequencing Rev (pTrcHisRev) GATTTAATCTGTATCAGG 
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Figure 2.2: A. The nucleotide sequence of the vector pProEX HTb was obtained 
from Addgenes (https://www.addgene.org/browse/sequence_vdb/3835/) and 
annotated in CLC Main Workbench v7.7 (QIAGEN). Highlighted regions of interest 
include the f1 origin (yellow), the origin of replication of the vector; lacI gene 
(red), the lactose inducer gene; ampicillin (blue), the ampicillin resistance gene 
and its promoter (green); the multiple cloning site for fragment insertion (grey;  
expanded in B); the trc promoter (green), the promoter associated with the 
multiple cloning site; the two PCR primer binding sites (pink) for the sequencing 
primers M13 pUC rev primer and pTrcHIS rev primer. 
B. Expanded region of the multiple cloning site showing the restriction enzyme 
recognition sites. The two enzymes used in this study, NcoI (340) and NotI (388), 
are highlighted in the red boxes. 
A
B
B
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PCR amplification was conducted using GoTaq® DNA polymerase (Promega) and genomic DNA as the 
template. The reaction cycles were 95°C for 5 minutes, 35 cycles of 95°C for 1 minute, 68°C for 1 minute 
(annealing temperature), 72°C for 1 minute for elongation and a final step at 72°C for 7 minutes to ensure 
thorough elongation.  
 The pProEX HTb vector was isolated from E. coli JM109 cells using a QIAprep Spin Miniprep Kit (Qiagen) 
as per the manufacturer’s instructions and was quantified using a NanoDrop ND-100 spectrophotometer 
(NanoDrop Technologies, Inc.). The plasmid vector and PCR product were digested with NcoI and NotI 
overnight in a 37°C water bath. The vector was then electrophoresed through an ethidium bromide-
stained agarose gel and visualised under low-wavelength UV in order to excise the appropriate DNA 
restriction fragment. The linear vector was cleaned using the Wizard® SV Gel and PCR Clean-Up Kit 
(Promega) as per the manufacturer’s instructions. The ligation reaction was performed at room 
temperature overnight with a 1:5 molar ratio of vector to insert DNA using T4 DNA ligase (Bio-Labs). The 
recombinant vector was then transformed into E. coli JM109 cells, made competent according to the 
protocol presented in Dagert & Ehrlich (1979). The cells were transformed using the heat-shock method 
presented in Seidman et al. (1997). 
The transformed cells were plated onto Luria agar (LA) supplemented with the selective antibiotic 
ampicillin (0.1 mg/ml final concentration). Appropriate controls were also performed to check the natural 
resistance of the strain, the transformation efficiency of an empty vector and the restriction digest of the 
vector. The positive colonies were screened for insert DNA using colony PCR with the primers used for 
subcloning and the primers that flank the DNA fragment inserted in the vector (sequencing primers). 
Colonies that showed the presence of insert DNA were incubated in Luria broth (LB) overnight and 
plasmids were extracted using the QIAprep Spin Miniprep Kit (QIAGEN) as per the manufacturer’s 
protocol. The isolated plasmids were sent for sequencing at Macrogen Europe to ensure that the insert 
had not incurred any mutations as a consequence of PCR amplification, restriction digest, ligation and 
transformation. The sequences were analysed using CLC Main Workbench and compared to an in silico 
clone of the same region. The sequences were also searched against the NCBI database using BLASTn to 
ensure that the region contained similarities to the H. midae haemocyanin gene.  
2.3.2 Recombinant protein production 
Recombinant pProEX plasmids with the haliotisin insertion confirmed via DNA sequencing were 
transformed into chemically competent E. coli BL21 as described in section 2.3.1. Transformed cells were 
cultured on LA supplemented with ampicillin (final concentration 0.1 mg/ml) to select for the presence of 
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the vector. Colonies resistant to the antibiotic were analysed for the presence of the recombinant vector 
using colony PCR. A single colony was resuspended in 10 μl of water and used as the template of a PCR 
with the cloning primers or a combination of the forward sequencing primer and the reverse cloning 
primer. The colonies that exhibited the correct amplicon size were inoculated into LB for growth overnight 
at 30°C with shaking. This culture was stored in 200 μl aliquots supplemented with 25% glycerol (final 
conc.) at -80oC for later use in recombinant expression.  
The three main factors that affect recombinant protein production are inducer concentration, the time 
from induction to harvesting and the temperature at which induction occurs. Other impactful factors 
include the optical density of the culture at the time of induction and the components of the media used 
to grow the cells. The BL21 cells containing the recombinant vector were grown overnight in LB at 30°C 
with shaking in order to generate a starter culture. The starter culture was used to inoculate 25 ml of LB 
in an 250 ml Erlenmeyer flask to a final optical density of 0.1 at 600 nm (OD600nm = 0.1). The 25 ml culture 
was grown to mid-log phase at 37°C with shaking (approximately 2 hours; OD600nm = 0.6). In order to 
induce the trc hybrid promoter present on the pProEX vector, a final concentration of 2 mM of isopropyl 
β-D-1-thiogalactopyranoside (IPTG) was added to the culture. The culture was induced for 4 hours at 37°C 
with shaking, and the cells harvested by centrifugation at 6 000 x g for 20 minutes and stored at -20°C 
until required for protein extraction.  
2.3.3 Protein extraction 
The cell pellet (section 2.3.2) was resuspended in a native buffer solution (100 mM Tris·Cl, 10 mM sodium 
chloride). The cell suspension was sonicated at an amplitude of between 6 and 10 µm for 30 second 
intervals and 15 second pauses for a total of 5 minutes. The cell suspension was kept cold in a methanol 
ice bath during sonication. Following initial lysis, the suspension was centrifuged at 20 000 x g for 15 
minutes and the supernatant saved as the soluble protein fraction. The pellet was then resuspended in 
native buffer supplemented with 8 M urea and a pH adjusted to 8.0 (denaturing buffer). The suspension 
was sonicated and centrifuged as before, and the supernatant saved as the insoluble protein fraction. 
Both supernatants were analysed on a SDS-PAGE to determine whether the expected 11 kDa putative 
antimicrobial peptide was included in the insoluble or soluble protein fraction. The protein sizes were 
determined by comparison to a PageRuler™ Prestained Protein Ladder (Thermo Fisher Scientific). The 
identity of the protein bands was confirmed as being the his-tagged peptide by performing a western blot, 
using two different primary antibody probes, as described in section 2.3.5.  
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2.3.4 SDS-PAGE 
 SDS-PAGE gels were made up according to the protocol in the appendix (5.1.1). For all protein separation 
the samples were run on a 15% resolving and a 4% stacking SDS-PAGE. Before loading onto the gel, 
samples were mixed with a 5 X sample application buffer (1 M Tris-HCl pH 6.8, 50% glycerol, 25% SDS, 
10 mg/ml bromophenol blue, 21% w/v dithiothreitol (DTT)) and boiled for 10 minutes. SDS-PAGE gel 
electrophoresis was performed at room temperature at 100V for 2 hour or until the dye front reached the 
end of the gel. Once complete, the gel was either stained to visualise the total proteins or the separated 
proteins bands were transferred to a nitrocellulose membrane for western blot analysis to detect the 
presence of the recombinant haemocyanin protein.  
Staining was performed overnight at room temperature with shaking, using Coomassie stain (0.5 g 
Coomassie blue G-250, 225 ml methanol, 50 ml acetic acid and 225 ml dH2O) and then destained using a 
destain solution (300 ml methanol, 100 ml acetic acid, 600 ml dH2O) before being visualised on a 
Molecular Imager® ChemiDoc ™ XRS+ (Bio-Rad) and analysed using Image Lab V5.2.1 (Bio-Lab).  
2.3.5 Western blot analysis 
To confirm that the band detected via SDS-PAGE was the expected peptide, western blot analysis was 
performed on two separate membranes, one probed with an anti-HIS antibody (Sigma SAB4301134) and 
the other with an anti-KLH antibody (Agrisera AS99 001). Proteins separated by SDS-PAGE were 
transferred to the nitrocellulose membrane at 10V for 1 hour using a Trans-Blot® SD Semi Dry Transfer 
Cell (Bio-Rad), and the presence of total protein was confirmed using a Ponceau S (Merck) staining 
protocol. The stain was prepared by dissolving 0.1% (w/v) Ponceau S in 1% (v/v) acetic acid. Once the 
proteins had been transferred, and prior to blocking, the membrane was immersed in the stain for 5 
minutes with shaking. After visualisation, the stain was removed via two rounds of washes with water for 
5 minutes each.  
Following staining, the membrane was blocked overnight using a 2% bovine serum albumin (BSA) 
phosphate-buffered saline (PBS) solution (137 mM NaCl, 10 mM phosphate, 2.7 mM KCl, pH 7.4). The 
membrane was then washed three times using a 2% Tween PBS (PBST) solution for 15 minutes per wash 
and a final wash of 1 x PBS. The primary anti-HIS antibody was diluted 1:2 000 and the primary anti-KLH 
antibody was diluted 1:10 000 in 2% BSA PBST. Each membrane was submerged in primary antibody 
suspension and incubated at 37°C with shaking for one hour. The primary was washed away with three 
sets of 15-minute washes with PBST and one 15-minute wash with PBS. The secondary antibody, Anti-
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Rabbit IgG (whole molecule)–Peroxidase produced in goat (Sigma A6154), was diluted 1:5 000 in 2% BSA 
PBST and added to the membrane. The membrane was submerged in the secondary antibody solution 
and incubated for one hour at 37°C with shaking, following which the same set of washes as above were 
conducted. Finally, 2 ml of horseradish peroxidase substrate, TMB membrane peroxidase substrate (KPL), 
was added to each membrane and allowed to develop in the dark for 30 minutes. The membrane was 
then photographed using a Molecular Imager® ChemiDoc™ XRS+ (Bio-Rad) and analysed using Image Lab 
V5.2.1 (Bio-Rad).  
2.4 Purification of the his-tagged putative AMP 
After the presence of the correct peptide was confirmed using SDS-PAGE and western blot analysis it was 
necessary to purify the haemocyanin from the bacterial host proteins. This was done using the 
polyhistidine-tag presented by the pProEX vector and nickel affinity chromatography. Two methods were 
employed, batch purification and fast protein liquid chromatography (FPLC).  
2.4.1 Batch purification of the his-tagged putative AMP 
For the batch purification The QIAexpressionist™ handbook (5th edition)(Qiagen 2003) was used as a 
guide. Protocol 17: Batch purification of polyhistidine-tagged proteins from E. coli under denaturing 
conditions (Qiagen 2003) was followed with some minor alterations. In summary, 1 ml of HisPur™ Ni-NTA 
Resin (Thermo Fischer Scientific) was combined with 10 ml of the lysate and made up to a final volume of 
15 ml using native buffer supplemented with 8 M urea. The suspension was incubated for one hour, 
according to the batch protocol, at room temperature on a rotisserie contained in a hybridization 
oven/shaker (Amersham Life Science) which was set at 10 revolutions per minute. The lysate was then 
carefully loaded into an empty Poly-Prep® Chromatography Colum (Bio-Rad). The bottom cap was 
removed and the flow-through collected. The column was then washed with three sets of 10 column 
volumes (CV) of denaturing buffer at pH 8, pH 7.4 and pH 6.7 respectively, collecting each of the fractions 
in 1.5 ml aliquots. Finally, the sample was eluted using the denaturing buffer supplemented with a final 
concentration of 250 mM imidazole.  
All the fractions were analysed on a NanoDrop at an absorbance of 280 nm to determine relative protein 
concentrations. This information was used to generate an elution profile and determine which of the 
fractions contained proteins. All fractions containing proteins were analysed by SDS-PAGE in order to 
determine whether they contained the expected 11 kDa peptide in a purified form.  
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2.4.2 Dialysis to remove urea from the buffer containing the putative AMP 
Dialysis was attempted in order to remove the urea from the buffer in which the purified peptide was 
suspended. A D-Tube™ Dialyzer Maxi (Merck), MWCO 6-8 kDa, was used for this purpose with the 
manufacturer’s protocol acting as a guide. A two-step dialysis was performed: initially using the native 
buffer supplemented with 3 M urea as the dialysate; and then using the native buffer alone as the 
dialysate. One litre of dialysate was used to dialyse 700 μl of the sample. Each step was conducted over a 
24-hour period with a single change of dialysate after 12 hours. The pH of the dialysate was altered with 
each change of buffer to reduce the overall pH from 8.0 to a more physiologically relevant 7.2 for 
downstream analysis. This was achieved by altering each solution to have a pH 0.2 lower than the solution 
it replaced. The resultant peptide was tested for activity in a radial diffusion assay (section 2.4.4), and the 
folding was examined using size exclusion chromatography (SEC). For SEC, the samples were filtered 
through a 0.2 μm filter and loaded onto a S75 16/600 column, the principle being that if the peptides 
within the sample all had the same configuration due to identical folding, the sample should elute in a 
single peak during the SEC.  
2.4.3 FPLC on-column folding and purification of the His-tagged peptide 
Using the method described by Oganesyan et al. (2005) as a guide, on-column refolding and purification 
of the H. midae putative antimicrobial peptide was attempted by changing the buffers during Fast Protein 
Liquid Chromatography (FPLC). After equilibration of the nickel-affinity column with the denaturing buffer 
(native buffer containing 8 M urea), the protein sample was loaded onto the column. The flow-through 
was collected and the column washed with 10 CV of 8 M urea, 20 mM Tris·Cl, 0.1 M NaCl at a pH of 8.0, 
following which 10 CV of the same solution at a pH of 6.7 was used to remove any non-specific binders. 
Five CV of the original denaturing buffer was then used to return the column to the original pH of 8.0.  
The next stage focussed on refolding the protein. All renaturation steps were carried out in Buffer A 
(20 mM Tris·Cl, 0.1 M NaCl, pH 8.0), with various additions dependent on the purpose of the buffer. The 
column was washed with 10 CV of 20 mM Tris·Cl, pH 8.0 containing 0.1% Triton X-100 and 500 mM NaCl. 
Instead of performing this as a sudden buffer change, the addition of the Triton containing buffer was 
carried out using a gradient over 5 CV. The detergent was added to wash out the urea while maintaining 
the peptide in its denatured state. Subsequently, 10 CV of Buffer A containing 5 mM of β-cyclodextrin was 
added to remove the detergent and assist with folding the peptide bound to the column. An additional 
wash with just Buffer A was performed to remove excess β-cyclodextrin.  
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Finally, the bound proteins were eluted using an imidazole gradient from 0 to 300 mM in Buffer A. Each 
fraction collected over the course of the FPLC protocol was examined by spectrophotometry at 280 nm 
to detect the presence of proteins. All fractions of interest were analysed by SDS-PAGE to check for the 
presence of the haemocyanin peptide. To determine the concentration of the peptide, unknown samples 
were run alongside samples of BSA of known concentration to perform densitometric analysis. Set 
quantities of BSA were loaded onto an SDS-PAGE, ranging from 0.2 to 2.4 μg per well. After Coomassie 
staining, the optical density of the protein bands within the gel was measured and given a quantitative 
value for each sample. This was used to create a standard curve of the BSA sample that related protein 
quantity to optical density. The optical density of the peptide in the unknown samples was then measured 
and could be related back to quantity using the standard curve.  By controlling the volume loaded onto 
the gel, protein concentration can also be determined. 
2.4.4 Radial diffusion antimicrobial assay 
The refolded putative antimicrobial peptide was examined for its ability to inhibit the growth of four 
bacteria. Two of the four were Gram-positive, Bacillus subtilis and Staphylococcus aureus, and two were 
Gram-negative, Escherichia coli and Vibrio anguillarum. The Vibrio species was the only marine bacterium 
tested and is the species that abalone encounter in their natural habitat, as well as being the primary 
cause for bacterial disease in farming conditions. V. anguillarum was grown in tryptic soy broth (TSB) 
(tryptone 17 g/l, peptone 3 g/l, glucose 2.5 g/l, NaCl 5 g/l and K2HPO4 2.5 g/l), while the other three 
bacteria were grown in Luria broth (LB) (tryptone 10 g/l, NaCl 10 g/l and yeast extract 5 g/l). S. aureus and 
E. coli were grown at 37°C with shaking, and V. anguillarum and B. subtilis were cultured at 30°C with 
shaking for 18 hours. The starter cultures were used to reinoculate fresh media to a final optical density 
at 600 nm of 0.1 (OD600nm = 0.1) which were subsequently incubated at the appropriate conditions to 
obtain mid-log phase cultures of each of the bacterial strains.  
For the radial diffusion assay, two agar types were used – Luria agar and tryptic soy agar, made by the 
addition of 1 g of SeaKem® LE Agarose (Lonza) per 100 ml of LB or TSB respectively. To create a lawn of 
bacteria, 100 μl of mid-log phase (OD600nm = 0.6) culture was added to 7 ml of molten agar, vortexed 
and plated onto a petri dish. The agar was left to dry in a laminar flow for one hour. Using a modified 
pipette tip, wells of approximately 7 mm in diameter were made in the agar and 20 μl of either peptide 
solution or control solution was added to each well. The plates were then incubated overnight at 37°C for 
E. coli and S. aureus, or 30°C for V. anguillarum and B. subtilis, to allow the bacteria to grow. Solutions 
that inhibited the growth of the bacteria were expected to show a zone of inhibition, demonstrated by a 
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lack of growth in the bacteria surrounding the well. To better visualise this, the agar was stained using 
Coomassie stain (section 2.3.4) and then photographed. Control solutions included a negative control (the 
native buffer used during purification) and two positive controls (the denaturing buffer used during 
extraction, containing urea, and a solution of ampicillin at a similar concentration to the peptide). The 
native buffer was included to ensure that any zone of inhibition surrounding the peptide was not due to 
compounds contained within the buffer. The denaturing buffer was included to ensure that all urea had 
been removed from the peptide-containing solution. If the zone of inhibition from the denaturing buffer 
was of a similar sizes to the peptide solution it would imply there is residual urea in the peptide sample. 
The ampicillin solution was used to confirm that the assay was performed correctly; this solution should 
show a clear zone of inhibition.  
2.4.5 Growth inhibition assay 
To quantify the activity of the putative haemocyanin antimicrobial peptide, a growth inhibition assay was 
conducted. The bacterial species that showed positive results for the radial diffusion assay, indicating the 
peptide could inhibit their growth, was further analysed. Bacteria were grown to mid-log phase 
(OD600nm = 0.6) and then diluted by performing a two-fold ten step serial dilution series.  An aliquot 
(100 µl) of each dilution was added to the wells of a 96-well TPP® tissue culture plate (Merck). For each 
bacterial species, the samples were divided in half; one half was treated with 1 μg of the putative 
antimicrobial peptide (test wells), and the control half was treated with an equal volume of the native 
buffer (control wells). Each bacterium was tested in duplicate. The 96-well plate was incubated, with 
shaking, for two hours at the temperature appropriate for the strain being tested (section 2.4.4). The 
turbidity (OD600nm) of the bacterial cultures in each well was then measured with a MultiSkan® Go 
(Thermo Fischer Scientific) spectrophotometer using SkanIt™ software v4.1 (Thermo Fischer Scientific). 
The turbidity of cultures were compared to the turbidity of control cultures. The inhibitory effects of 1 μg 
of putative AMP was indicated when the turbidity of test cultures was lower than the turbidity of the 
controls. Consequently, a student’s T-test was conducted to compare the test and control wells for each 
stage of the two-fold dilutions.  
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3. Results 
3.1 Sequencing and analysis 
The full coding sequence of functional units e, f, g and h of the H. midae haemocyanin was determined 
(Supplementary Figure 5.1). The primer binding sites for the five sets of sequencing primers and the 
cloning primers are shown in Figure 3.1.  The binding sites for the FU-e forward and the FU-h reverse 
primers were trimmed from the 5’ and 3’ ends, respectively, during sequence analysis. Figure 3.1 shows 
the location of each of the functional units as compared to the H. tuberculata haemocyanin sequence, 
 
Figure 3.1: Diagram depicting annotated sequence data for H. midae haemocyanin 1 functional units a-h. 
Green arrows, binding regions for sequencing primers; grey arrows, binding regions for primers used for 
subcloning. Blue arrow indicates the haliotisin peptide region. The four sequenced functional units are: 
FU-e (light red), FU-f (dark red), FU-g (dark blue) and FU-h (purple). The complete sequence can be found 
in Supplementary Figure 5.1. 
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while Figure 3.2 illustrates the locations of the introns and exons in relation to H. tuberculata genomic 
and coding sequences. The region identified as being similar to the haliotisin peptide identified by Zhuang 
et al. (2015) is located in FU-e (Figure 3.1).  
The presence of functional units e, f, g and h in the H. midae haemocyanin sequence was confirmed by 
aligning the H. midae sequence to the H. rubra coding sequence, the H. tuberculata coding sequence and 
the H. tuberculata genomic sequence (Figure 3.2).  The H. midae haemocyanin sequence aligned between 
nucleotides 5101 and 9765 of H. rubra, indicating that it contained the majority of Fu-e, the entire FU-f 
and -g and most of FU-h, but excluding the final C-terminal portion.  
A BLASTn search of the NCBI database revealed that the H. midae sequence was most similar to the 
haemocyanin of the Australian black lip abalone H. rubra, with a 97% identity and 100% query cover. The 
second hit was to the northeast Atlantic and Mediterranean H. tuberculata haemocyanin 1 with 90% 
identity and 100% query cover. The H. tuberculata haemocyanin 1 sequence is the most complete and 
annotated sequence available for molluscan haemocyanin, with both genomic and coding sequences 
available. The H. tuberculata haemocyanin 2 sequence had a lower query cover and identity (41% and 
74% respectively) to the H. midae haemocyanin sequence, indicating that H. midae haemocyanin 1 is the 
sequence obtained in this study.  The phylogeny of the abalone haemocyanin sequences is represented 
in the cladogram in Figure 3.3.  
 
Figure 3.2: Alignment of the Haliotis tuberculata haemocyanin 1 sequence (HtH1 – genomic) with the coding 
sequences of H. tuberculata (HtH1 CDS), H. rubra (HrH1 CDS) and the H. midae HmH1 FU-e–h sequence obtained in 
this study. Exons located in the genomic sequence are highlighted in green and introns are highlighted in red (linker 
introns) or blue (internal introns). 
FU-hFU-gFU-fFU-eFU-dFU-c
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An H. midae contig (AJ749649.1) was most similar to the sequence obtained in this study (Figure 3.3). It 
must be noted, however, that this sequence is only 570 base pairs long and therefore does not align 
correctly with the other sequences included in the cladogram. The length of the other sequences included 
in the cladogram were trimmed to match the length of the four functional units (FU-e–h) obtained in this 
study. As noted previously, the H. rubra haemocyanin sequence shared the next most similarity with the 
H. midae sequence obtained in this study and hence, is associated with the most recent branching event 
in the cladogram. Older evolutionary branching events can be distinguished for H. tuberculata and 
H. diversicolor. All these branching events contained a bootstrap value of 100, indicating that the nodes 
are well supported.  
Haemocyanin 1 of the keyhole limpet Megathura crenulata has the highest sequence identity to the 
H. midae haemocyanin sequence in comparison to the other non-members of the Haliotidae superfamily 
(Figure 3.3). It should be noted that the commercially available antibody to haemocyanin used in this 
 
Figure 3.3: Cladogram showing sequence similarity between H. midae Sequence (FU-E,F,G,H) and other 
haemocyanin sequences from the NCBI database. Helix locorum (GenBank: JF752344.1), Aplysia californica 
(GenBank: AJ556169.1), Sepia officinalis (GenBank: KF306341.1), Octopus dofleini haemocyanin A (GenBank: 
AY751301.1), Nautilis pompilus haemocyanin (GenBank: AJ619741.1), Nucula nucleus haemocyanin (GenBank: 
AJ786639.1), Haliotis tuberculata haemocyanin 2 (GenBank: AJ297475.1), Haliotis rubra haemocyanin 2 
(GenBank: KU496943.1), Megathura crenulata haemocyanin 2 (GenBank: AJ698342.1), Megathura crenulata 
haemocyanin 1 (GenBank: AJ698341.2), Haliotis diversicolor haemocyanin 1 (GenBank: GQ352369.1), Haliotis 
tuberculata haemocyanin 1 (GenBank: AJ252741.1), Haliotis rubra haemocyanin 1 (GenBank: KU496942.1), 
Haliotis midae contig sequence (GenBank: AJ749649.1). 
Orange branches on the cladogram represent the haemocyanin 1 isoform, while the blue branch represents the 
haemocyanin 2 isoform. The green labels all the gastropod sequences. The red labels all the cephalopod 
sequences. Vetigastropoda includes the superfamilies Haliotidae and Fissurellidae. The cladogram was created 
using CLC Genomics Workbench 7.0 (https://www.qiagenbioinformatics.com/). 
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study (section 3.2.1) was raised against this protein. The next Vetigastropoda clade consists of 
haemocyanin isoform 2 sequences, suggesting that the two haemocyanin isoforms are evolutionarily 
distinct.  
The next cluster includes bivalve and cephalopod haemocyanin sequences from Nucula nucleus (clam), 
Nautilus pompilus (chambered nautilus), Octopus dofleini (giant Pacific octopus) and Sepia officianalis 
(common cuttlefish) (Figure 3.3). This cluster reflects haemocyanin sequence differences between 
cephalopods and gastropods, as well as the phylogeny of the two classes of invertebrates. The oldest 
branching event involves two gastropod haemocyanins from the terrestrial snail Helix locorum and the 
sea slug Aplysia californica.  
3.1.1 Antimicrobial peptide analysis 
The nucleotide sequence of the four functional units of the H. midae haemocyanin was translated using 
CLC Main Workbench v7.7 (QIAGEN) and divided into overlapping 70-amino-acid peptide sequences for 
input into the APD3: Antimicrobial Peptide Calculator and Predictor. This was necessary as the prediction 
engine is only able to process peptide sequences of 100 amino acids at a time. Each peptide sequence was 
searched against the database for similarity to antimicrobial peptide (AMP) structures and amino acid 
sequences of known antimicrobials. Whilst the majority of the fragments returned a potential helix 
structure, the highest similarity to known antimicrobials was only 31.1%. However, a 58-residue peptide 
located between amino acids 250 and 308 displayed 83.3% similarity to an AMP with accession number 
AP02446. Since this peptide is the haliotisin peptide from the abalone species H. tuberculata identified by 
Zhuang et al. (2015), it is likely that FU-e of the H. midae haemocyanin contains the same haliotisin peptide 
that occurs in other abalone species. The deduced amino acid sequence of the H. midae peptide was 
N - DTFDYKKFGYRYDSLELEGRSIAHLDELIKERQEQDRTFAGLLKGFGTSAT - C. This peptide has a total 
hydrophobic ratio of 29% and a total net charge of -3, while its protein-binding potential was determined 
to be 2.56 kcal/mol. Thus, the small size and a high proportion of hydrophobic residues in this region of 
the H. midae haemocyanin suggests that it is highly likely that it functions as an antimicrobial peptide. 
Although peptide regions from functional units f and g also displayed similarities to the haliotisin peptide, 
the similarity was limited to 40.8% and 36.1% respectively. There was no similarity between FU-h and the 
haliotisin peptide or its derivatives. Conservation of amino acids comprising the haliotisin peptide region 
of haemocyanins from a number of molluscs is depicted in Figure 3.4. The full nucleotide sequence 
alignment between haemocyanins from H. midae and various molluscan species is included in the 
appendix (Supplementary Figure 5.2).  
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3.1.2 AMP structure analysis 
The next step was to examine whether the haliotisin-like peptide identified in the H. midae haemocyanin 
contained β-sheets or α-helices and whether the helices, if present, were amphipathic in nature. 
Figure 3.5 shows the predicted 3D model of the peptide described in section 3.1.1. The peptide displays 
three secondary structures: an α-helix, a broken α-helix and a β-sheet domain, which is equivalent to the 
entire P3-P4-P5 peptide identified by Zhuang et al. (2015). Each specific domain also shows a high degree 
of hydrophobic amino acids (Figure 3.5B). The β-sheet specifically contains a majority of hydrophobic 
residues. Analysis of the full α-helix (N – IAHLDELIKERQE – C) for amphipathicity showed that the majority 
of non-polar residues were associated with one side of the helix (Figure 3.5C), thus demonstrating that 
the α-helix has an amphipathic structure and implying it is potentially capable of antimicrobial activity.  
 
Figure 3.4: Multiple sequence alignment between the FU-e of haemocyanins from a number of molluscs, showing the 
degree of amino acid conservation (black-shaded regions are more highly conserved). Amino acids identical to that of the 
H. midae sequence are substituted with a dot. The region that includes the haliotisin peptide is marked by a green rectangle. 
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3.2 Recombinant expression of AMP 
PCR amplification was used to amplify the portion of the H. midae haemocyanin gene that coded for the 
putative haliotisin peptide for subsequent sub-cloning into the pProEX vector in order to recombinantly 
express the peptide. Agarose gel analysis of the PCR products obtained by colony PCR of the E. coli BL21 
transformants confirmed sizes of the amplicons expected to be generated by the two sets of primers. The 
gene-specific primer pair (H. midae haliotisin cloning Fwd (Nco1) and H. midae haliotisin cloning Rev 
(NotI); Section 2.3.1: Table 2.2) yielded an amplification product of 178 base pairs, while amplification 
with the forward sequence primer (pProEX sequencing Fwd (M13Rev); Section 2.3.1: Table 3.1) and the 
 
Figure 3.5: 3D ribbon structures of the Haliotisin peptide from H. midae. A Full ribbon depicting the three 
domains present: green, α-helix; yellow, β-sheet; white is a portion of the pProEX vector. B Shows the 
hydrophobic components of the domains, where red indicates hydrophobic residues and blue indicates 
hydrophilic residues. C Representation of the α-helix depicting polar and non-polar residues to imply 
amphipathicity. 
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C
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gene-specific reverse primer (H. midae haliotisin cloning Rev (NotI)) yielded an amplicon of 285 base pairs. 
DNA sequences of the amplicons confirming that the recombinant plasmids contained the correct 
haliotisin region are included in the appendix (Supplementary Figure 5.3).  
 
Figure 3.6: Colony PCR of E. coli BL21 colonies containing pProEX with the H. midae haliotisin peptide inserted 
in frame to the His-tag of the vector. Primer sets were gene specific (Lanes A, C, E, G, I) or the forward 
sequencing primer and the reverse gene specific primer (Section 2.3.1: Table 2.2) (B, D, F, H, J). Ladder used 
was OneMARK100 from GeneDirex. 
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3.2.1 Protein expression 
Optimal expression of the H. midae haliotisin-like peptide in E. coli BL21 resulted by growing log-phase 
cells (OD600nm = 0.6) in the presence of IPTG at a final concentration of 2 mM for 4 hours at 37°C with 
shaking. The expressed peptide was detected in the insoluble E. coli protein fraction (Figure 3.7). 
Consequently, cells were lysed using the denaturing conditions described in section 2.3 to obtain 
increased peptide yields.  The identity of the putative haliotisin was confirmed by western blot, using an 
antibody to the his-tag presented by the pProEX vector and a commercial haemocyanin antibody raised 
against keyhole limpet haemocyanin (KLH). Although non-specific bands are evident, a band situated just 
below the 15 kDa marker is evident in the induced samples and absent from the uninduced controls, 
indicating that the haliotisin-like peptide from H. midae was expressed in E. coli BL21 transformants 
(Figure 3.8).  
 
Figure 3.7: SDS-PAGE showing proteins extracted from E. coli BL21. A 
BL21 control cells lysed using native buffer. B Transformed cells lysed 
with native buffer. C Post-sonication pellet resuspended in denaturing 
buffer. D Transformed cells lysed using denaturing buffer. Putative 
haliotisin peptide highlighted in green box. Ladder used was 
PageRuler ™ Prestained protein ladder (Thermo Fisher Scientific). 
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3.2.2 Purification of the H. midae haliotisin-like peptide 
The putative haliotisin-like peptide expressed in E. coli BL21 was purified from the host proteins using the 
his-tag fused to the N-terminal end of the cloned H. midae haemocyanin fragment. Initial batch 
purification using HisPur™ Ni-NTA resin yielded positive results, with the peptide eluting at an imidazole 
concentration of 250 mM (Figure 3.9). However, additional proteins eluted together with the targeted 
peptide. Since a lower concentration of imidazole (20 mM) still seemed to elute the H. midae peptide, an 
alternate protocol for removing the non-specifically bound proteins was attempted which involved 
lowering the pH of the wash buffer from 8.0 (used for cell lysis) to 6.7. As can be seen in Figure 3.10, the 
revised protocol improved the purity of the haliotisin-like peptide, despite the presence of an additional 
protein (approximately 25 kDa) eluting from the HisPur™ Ni-NTA resin. Although still to be confirmed, this 
band may be a dimerised form of the H. midae peptide.  
 
Figure 3.8: Western blots of protein extracted from 
haliotisin-expressing E. coli BL21 transformants. Protein 
extracted from cells induced for 4 (A), 6 (B) and 8 (C) hours 
compared to uninduced cells (D). Arrow indicates the band 
present in induced samples. Ladder was PageRuler™ 
Prestained protein ladder. (Thermo). 
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Figure 3.9: Batch purification using HisPur™ Ni-NTA resin. A. Elution profile showing an absorption 
peak at A280nm following the addition of imidazole at the start of the elution step. B. SDS-PAGE of 
the eluted samples (FT=Flow Through, W=Wash, E=Elution). The numbers correspond to the fraction 
number. Ladder: PageRuler ™ Prestained protein ladder (Thermo Fisher Scientific).  
 
 
Figure 3.10: SDS PAGE of eluted fractions after washing with denaturing buffer at pH6.7. E: Elution 
fractions.  Ladder: PageRuler™ Prestained protein ladder (Thermo Fisher Scientific) 
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3.2.3 Dialysis 
In order to allow the purified H. midae haliotisin-like peptide to refold into the active state, it is necessary 
that the urea is removed from the sample buffer. Thus, removal of urea from the denaturing buffer was 
attempted by dialysis for a total of 48 hours (section 2.4.2). Size-exclusion chromatography (section 2.4.2) 
was used to investigate whether the peptide had indeed refolded to the active conformation, while a 
radial diffusion assay was employed to investigate the antimicrobial activity of the peptide (section 3.3; 
Figure 3.13i). Theoretically, if the peptide had folded correctly following dialysis to remove the urea, it 
should elute from the size-exclusion column as a single peak in the A280nm profile. However, no distinct 
peaks were visible in the elution profile, suggesting that the peptide had folded in a variety of 
conformations and consequently, had eluted throughout the size-exclusion column (Supplementary 
Figure 5.4), thus requiring an alternate protocol to obtain a correctly folded, biologically functional 
peptide.  
3.2.4 Fast protein liquid chromatography 
In collaboration with the Chemical Engineering Department at UCT, an on-column refolding and peptide 
purification protocol, adapted from Oganesyan et al. (2005), was performed using fast protein liquid 
chromatography, the elution profile for which can be seen in Figure 3.11.  
It is evident that there is a peak in absorbance at the start of the protocol (Figure 3.11A). This is 
representative of proteins that were unable to bind to the column and flowed through in the initial buffer. 
The change in pH of the denaturing buffer causes a slight increase in the absorbance readings, barely 
detectable in the figure, which is representative of the non-specifically-bound proteins being eluted.  
The erratic absorbance readings steadily increase as buffer containing the Triton detergent is added to 
the column (Figure 3.11B). Since Triton is known to absorb at 275 nm, a wavelength close to the 280 nm 
being examined, it is likely that the detergent is the cause of the increased absorbance. It is important to 
note that the absorbance values of the elution profile shown in Figure 3.11B are lower than those 
observed in the profile depicted in Figure 3.11A. The latter elution profile peaked at 5 000 mAU (milli-
absorbance units), while the former (Figure 3.11B) peaked at around 1 800 mAU. The addition of 
β-cyclodextrin resulted in the final peak in the elution profile, presumably coinciding with the removal of 
the remaining Triton from the column (Figure 3.11B).  
Four distinct peaks were evident in the elution profile generated during the elution stage of the fast 
protein liquid chromatography protocol (Figure 3.11C). The absorbance over the elution profile was much 
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Figure 3.11: Elution profiles showing the three stages of the refolding and 
purification process performed with FPLC. Y-axis: absorbance at 280 nm 
normalised to the sample buffer. X-axis: the fraction number (red) and volume 
in ml (black). A. Elution profile for the initial flow-through and washes using a 
reduced pH urea buffer. B. The elution profile for the refolding step following 
addition of the detergent Triton and the cyclic oligosaccharide β-cyclodextrin. 
C. The elution step using an imidazole gradient. The blue line represents 
absorbance and the green line indicates the ratio of the two buffers. Each peak 
in absorbance has been labelled (1-4). 
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lower, peaking at only 450 mAU, which suggests that the concentration of the protein eluted from the 
column was very low.  
All fractions obtained from the three stages of the fast protein liquid chromatography protocol that had 
absorbance readings higher than baseline were analysed by SDS-PAGE to determine the size of the 
proteins and the location of the recombinant haliotisin-like peptide. SDS-PAGE of the fractions containing 
the four peaks observed in the profile of the elution stage of the protocol (Figure 3.11C) showed that the 
fourth peak, located in fractions 21 and 22 of the elution profile (Figure 3.11C), included the purified 
H. midae peptide (Figure 3.12). The fourth peak (fractions 21 and 22) also appear to contain a double band 
for the recombinant protein. Fast protein liquid chromatography removed the large, non-specific proteins 
and returned the recombinant haliotisin-like peptide at a greater degree of purity. However, since elution 
was performed in 5 ml fractions, the concentration of the peptide was much lower than that obtained by 
batch HisPur™ Ni-NTA resin purification where the fractions were collected in 100 μl aliquots.   
The fractions containing the H. midae haliotisin-like peptide, as determined by SDS-PAGE (Figure 3.12), 
were pooled and concentrated to obtain a workable concentration that would allow screening of the 
antimicrobial potential of the peptide. Thus, the sample was placed in an Amicon ® Ultra with 3 kDa 
MWCO (molecular weight cut off) (Merck) and centrifuged at 5 000 x g until the total volume reached the 
minimum of 200 μl in accordance with the manufacturer’s protocol. The concentrated sample containing 
the haliotisin-like peptide and known concentrations of bovine serum albumin (BSA) samples were 
 
Figure 3.12: SDS-PAGE of elutions from FPLC refolding and purification. The four peaks 
indicated here correspond to the four peaks indicated in the profile of Figure 3.11C. The 
fraction numbers are in red to correspond with the red fraction numbers of Figure 3.11C. The 
green box indicates the faint band corresponding to the haliotisin-like peptide. Other bands 
indicate eluted non-specifically bound proteins.  
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subjected to SDS-PAGE. After staining the polyacrylamide gel, the concentration of the haliotisin-like 
peptide could be determined by densitometric analysis (section 2.4.3) (Supplementary Figure 5.5). Even 
after the putative haliotisin peptide had been concentrated to the lowest possible volume using the 
Amicon® Ultra Centrifugal Filter (Merck), the final concentration of the purified protein remained low 
(between 50 and 100 μg/ml).   
3.3 Antimicrobial activity 
The most accurate strategy for determining whether a protein is correctly folded is to test the peptide for 
activity. Therefore, despite the low concentration of the purified haliotisin-like peptide, a radial diffusion 
assay was performed in order to examine whether the peptide could inhibit the growth of four different 
bacterial species. Zones of inhibition were evident in two of the four strains tested. The E. coli strain 
incubated with the batch-purified and dialysed haliotisin-like peptide sample (Figure 3.13i) and the 
S. aureus strain incubated with the concentrated FPLC-purified and refolded sample (Figure 3.13ii) both 
showed zones of inhibitions. The zone of inhibition for E. coli had a radius of 4 mm and the zone of 
inhibition for S. aureus had a radius of 7.5 mm. No zones of inhibition were visible for the native buffer in 
either of these radial diffusion assays. The two positive controls for the assay – the denaturing buffer and 
the ampicillin sample – both show zones of inhibition larger than that present in the peptide sample. The 
zone of inhibition for E. coli had a radius of 11 mm when treated with the denaturing buffer that contained 
urea, and the zone of inhibition for S. aureus had a radius of 15.5 mm when treated with ampicillin at a 
concentration equal to that of the peptide sample. The other two strains of bacteria tested, B. subtilis and 
V. anguillarum, showed no zones of inhibition (Supplementary Figure 5.6). The zones of inhibition in both 
the E. coli and S. aureus strains suggest that the putative haliotisin-like peptide from H. midae is able to 
inhibit the growth of these Gram-negative and Gram-positive bacterial species, although additional 
experiments are required to confirm this activity.  
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3.3.1 Quantitative growth inhibition assay 
Since the data obtained using the radial diffusion assay was only suggestive due to the qualitative nature 
of the assay the antimicrobial potential of the H. midae haliotisin-like peptide was further investigated 
using a quantitative growth inhibition assay. Only the two bacterial species that showed zones of 
inhibition (section 3.3) were tested. Two-fold serial dilutions of logarithmic growth-phase E. coli and 
S. aureus cultures were prepared and tested against 1 μg of the H. midae haliotisin-like peptide. Optical 
density of the E. coli cultures diluted from 1:128 to 1:512 showed significant decrease when incubated 
with the putative H. midae haliotisin-like peptide (Figure 3.14A). When incubated with the peptide, the 
E. coli cultures at lower dilutions (1:128, 1:256 and 1:512) achieved an optical density of only 34.8%, 18.9% 
and 13.7% respectively, relative to the control cultures at the corresponding dilutions. This shows that 
with less bacteria present, the low-concentration putative antimicrobial peptide was highly effective at 
inhibiting the growth of the Gram-negative E. coli.  
Throughout the two-fold dilutions series, the optical density of the S. aureus cultures, when compared to 
corresponding uninhibited controls, showed a trend of being reduced when incubated with the putative 
H. midae haliotisin-like peptide (Figure 3.14B). Significant differences were only visible in four of the tested 
dilutions (undiluted, 1:2, 1:8 and 1:32) showing no trend, but this may be due to having only conducted 
 
Figure 3.13: Stained agarose plates showing results of radial diffusion assay 
i) E. coli exposed to water (A), 8M urea buffer (B), haliotisin peptide (C) and native buffer (D) 
ii) S. aureus exposed to native buffer (A), 8M urea buffer (B), haliotisin peptide (C) and equal 
concentration of ampicillin (D). 
I. II. 
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C D
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D
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two technical repeats due to a limited amount of purified peptide available for the assay. The S. aureus 
strain, when incubated with peptide, was still able to achieve an optical density greater than 65% of that 
reached by the corresponding uninhibited controls, showing that the peptide had a weak inhibition of the 
S. aureus regardless of bacterial concentration. The data thus suggests that the H. midae haliotisin-like 
peptide is able to inhibit growth of both E. coli and S. aureus, but its ability to inhibit the growth of this 
Gram-positive bacterium is significantly less potent than its inhibitory effect on the Gram-negative 
bacterium.  
 
Figure 3.14: Optical density readings for bacterial cultures of E. coli (A) and S. aureus 
(B) incubated in the presence or absence of the haliotisin-like peptide from H. midae. 
* indicates significant decrease in growth when incubated with peptide compared to 
bacterial culture of the same starting concentration (P<0.05). 
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4. Discussion 
4.1 Sequence analysis 
Based on the upregulation of haemocyanin in response to Vibrio infection (Beltran 2015), further 
investigation of the role that haemocyanin, a large multimeric oxygen transporter, could have within the 
innate immune response of the South African abalone H. midae was undertaken. To start, a greater 
knowledge surrounding the sequence of the gene was required. The sequence presented in this study is 
the longest sequence of H. midae haemocyanin recorded to date. The gene showed high sequence 
similarity to the Australian black lip species H. rubra and demonstrated that the most prevalent 
haemocyanin present in H. midae is haemocyanin isoform 1. The two haemocyanin isoforms in Haliotidae 
seem to have evolved as a result of a duplication event that occurred c.350 million years ago (Streit et al. 
2005), but the significance of there being two isoforms is still not completely understood. Primers 
designed with the second isoform of H. rubra as the template yielded no products when used for PCR 
amplification in this study, so it is not certain whether H. midae even contains the haemocyanin isoform 2. 
In some organisms, the expression of one isoform tends to dominate the other, and only arthropods are 
known to contain an equal ratio of the two haemocyanin isoforms. The two isoforms generally appear in 
a 3:1 ratio of isoform 1 : isoform 2 in abalone haemolymph (Altenhein et al. 2002; Keller et al. 1999).  
4.1.1 Phylogeny of haemocyanin 
The cladogram presented in Figure 3.2 agrees with data reported in other studies. Streit et al. (2005) found 
two clades present within the Haliotidae haemocyanin gene: a “short”-intron-possessing group of 
European and Australasian origin and a newer “long”-intron-possessing group, primarily from the North 
Pacific. Data from Streit et al. (2005) also provided evidence of a divergence from the superfamily 
Fissurellidae (represented by Megathura crenulata in Figure 3.2) c.260 million years ago, which accords 
with fossil records. For the current study, only the European and Australasian branch was utilised for the 
cladogram, but the divergence patterning and separation of the second isoform can be seen in both the 
data presented here and the data collected by Streit et al. (2005). The divergence of the gastropod species 
from the cephalopod species is also evidenced by the separation of the octopus, cuttlefish and nautilus 
sequences from the abalone and limpet sequences. 
The Haliotis haemocyanin sequences all clustered together and associated with the Megathura crenulata 
sequence in a separate clade from the rest of the analysed haemocyanin sequences. The two 
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haemocyanin isoforms must have emerged after this divergence event, as evidenced by the grouping of 
isoform 2 sequences within the Vetigastropoda clade. The only peculiar finding in this figure is the 
isolation of the Helix locorum sequence away from the rest of the gastropod haemocyanin sequences. 
This terrestrial gastropod showed the earliest divergence away from the rest of the Haliotis species, 
suggesting that a large modification to the haemocyanin sequence was required for terrestrial life.  
4.1.2 Functional unit e 
Obtaining the full sequence of the haemocyanin gene was outside of the scope of this project, so for this 
study, the four subunits on the C-terminal end of H. midae haemocyanin were sequenced. This included 
the majority of FU-e and FU-h and the entirety of FU-f and FU-g, which had a maximum of 49% identity to 
one another at the protein level, in accord with the findings of previous studies (Lieb & Markl 2004). As 
Fu-e has been shown to play a role in the immune response (Zhuang et al. 2015; Dolashka & Voelter 2013; 
Zhu et al. 2014), it became the primary focus of a search for antimicrobial activity.  
The linker region between the α-helix-rich domain and the β-sheet domain has been shown to have an 
impact on haemocyanin’s function as a pro-phenoloxidase in molluscs, with structural alterations also 
associated with the conversion of haemocyanin into an immune-enzyme in crustaceans and chelicerates 
(Coates & Nairn 2014; Van Holde et al. 2001; Hristova et al. 2008; Kostadinova et al. 2013; Lee et al. 
2003a). Zhuang et al. (2015) propose that haemocyanin is processed via an as yet uncharacterised 
proteolytic cleavage that causes the tertiary structure to loosen and enables the haemocyanin-derived 
phenoloxidase activity, which could also result in the release or generation of bioactive peptides such as 
haliotisin. Zhuang et al. (2015) further propose that a combination of host- and microbe-directed 
mechanisms could cause the release of haliotisin peptides by serine protease-like enzymes and, during 
the process, disturb the structural elements surrounding the dicopper centre of haemocyanin, which 
would allow phenols a mode of entry to the copper-bound O2.  
Dolashka et al. (2010) demonstrated the ability of glycosolated Fu-e isolated from R. venosa, the veined 
Rapa whelk, to stop viral replication of herpes simplex virus type 1. Additionally, Zhu et al. (2014), through 
work on H. diversicolor, demonstrated that when haemocyanin loses its inter-functional unit interactions, 
FU-e has an enhanced ability to oxidise diphenols. It is proposed that, during infection, enzymes target 
haemocyanin FU-e to signal the need for immune function through anti-viral activity (Dolashka & Voelter 
2013), phenoloxidation (Zhu et al. 2014), the production of antimicrobial peptides such as haliotisin 
(Zhuang et al. 2015) or a combination of these responses.  
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4.1.3 Antimicrobial sequence analysis 
The APD3 predictions returned a large number of potential helices for the inputted haemocyanin 
sequences, particularly on the N-terminal end of each functional unit, which accords with the data 
previously presented that found that this region contains a helix-rich domain (Lieb et al. 2000; Keller et al. 
1999; Lieb et al. 2001). However, apart from the haliotisin-like region, none of these potential helices 
shared more than 30% identity with any other known antimicrobial peptide, suggesting that these helices 
are not likely to act as antimicrobial peptides. Some putative peptide fragments were predicted to have a 
cysteine-rich region, but again these showed low similarity to known AMPs.  
The hydrophobicity of the peptide found in FU-e of H. midae was determined to be 29%, very close to the 
28% hydrophobicity content of the haliotisin peptide reported by Zhuang et al. (2015). The protein-binding 
potential was also very similar: 2.56 kcal/mol for this study’s peptide and 2.82 kcal/mol reported in the 
Zhuang et al (2015) study. The protein-binding potential of the peptide is unrelated to this study, as the 
potential membrane-binding function of the peptide involves lipids rather than proteins (Boman 2003). 
These findings suggest that the peptide isolated from FU-e of H. midae in this study should have the same 
bioactivity as the haliotisin peptides synthetically created by Zhuang et al. (2015).  
Regions with a degree of similarity to the haliotisin peptide were also found in FU-f and FU-g, but these 
were partial alignments and not the full peptide sequence observed in FU-e. This indicates that either the 
haliotisin peptide-coding region was present within all the functional units after the duplication event and 
subsequently, portions of it in FU-f and FU-g were lost due to deletions; or an ancestral version of the 
peptide was present in each functional unit after the duplication event, and only FU- e adapted this coding 
region to form the haliotisin-like peptide.  
The 3D-structure prediction of the haliotisin-like peptide shows the same features presented by Zhuang 
et al (2015) and is compared in Figure 4.1, where the P3, P4 and P5 peptide regions are shown to be 
contained within the cloned segment of haliotisin used in this study. The red-highlighted region represents 
the P3 peptide, which Zhuang et al. (2015) found to have high anti-proliferating activity against the Gram-
positive bacterium B. subtilis, while a combination of P4 (green) and P5 (blue) exhibited the highest activity 
against the tested E. carotovora strain, representing Gram-negative bacteria. This indicates that the 
peptide used in this study contains all three motifs presented by Zhuang et al. (2015) and should have 
similar effects on both Gram-negative and -positive bacteria. The P3-P4-P5 is thought to contribute one 
continuous peptide with antimicrobial properties.  
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The organisation of amphipathicity within the helix (Figure 3.5C) shows that it is most likely to associate 
with the membrane of the bacterial cell wall and cause disruption. The portion of the helix that contains 
an abundance of non-polar residues will most likely associate with the lipid core of the bacterial 
membrane and cause the formation of pores through one of the three proposed methods by Brogden 
(2005) and described in section 1.2.1, although which specific method is not known. Zhuang et al. (2015) 
used transmission electron microscopy to show cell wall abnormalities, demonstrating that the haliotisin 
peptide inhibits growth through lesions in the bacterial cell wall. Because the alpha helix present in the 
haliotisin-like peptide of this study demonstrates a high degree of similarity to the one presented by 
Zhuang et al. (2015), it is likely that the two peptides have a similar function.  
4.2 Recombinant production of the peptide 
During the recombinant production of the haliotisin-like peptide, the growth and induction conditions 
yielded the peptide within the insoluble fraction of the lysed E. coli cells. The growth conditions were 
modified in an attempt to obtain a soluble version of the peptide, but this resulted in reduced growth of 
the hosting E. coli cells. Induction at a lower temperature for a longer period of time should allow for the 
cells to produce and correctly fold the peptide, as it does not contain many complex features and should 
thus fold correctly in a prokaryotic organism such as E. coli. However, there was a significant reduction in 
the optical density of the culture when these conditions were tested (incubation at 20°C for between 12 
and 18 hours after inducing with 2 mM of IPTG), implying a reduced number of cells. The uninduced 
controls were able to grow sufficiently over this time period, suggesting that the reduction in cell density 
is directly related to the production of the peptide over this period. The reduction in E. coli growth and 
 
Figure 4.1: 3D ribbon models of (A) The haliotisin-like peptide investigated in this 
study and (B) The haliotisin peptide identified by Zhuang et al. (2015). Red indicates 
the P3 peptide described in the Zhuang study, green indicates the P4 peptide and 
blue indicates the P5 peptide.  
 
A B
58 | P a g e  
 
replication under these conditions may be a result of resource-intensive recombinant protein production, 
leaving insufficient energy for culture maintenance. An alternative hypothesis is that the peptide was 
produced and correctly folded, becoming functionally active as an AMP and inhibiting the growth of the 
bacteria. Consequently, it was decided that the best course of action would be to induce at a higher 
temperature for a shorter period of time to encourage the cells to form inclusion bodies of the peptide 
and then isolate the haliotisin-like peptide from the insoluble fraction post-lysis for purification and 
refolding at a later stage.  
The process could be improved by initially lysing the E. coli with the native buffer and then resuspending 
the insoluble fraction in the denaturing buffer, as was done for the results presented in Figure 3.7. This 
would allow for an initial purification step to eliminate all the E. coli cytoplasmic host proteins from further 
purification steps. The insoluble proteins alone could be used for batch purification or FPLC purification, 
which would result in a reduced chance of non-specific binding due to fewer proteins in the sample. 
Reducing the total number of proteins in the sample would also reduce the likelihood of the peptide 
binding to another protein during refolding protocols. 
During the batch purification the incubation of the cell lysate with the affinity resin could be increased to 
24 hours, which may increase the yield of purified protein produced. The binding process is generally a 
slow one and by only binding for one hour it is possible that a lot of the target protein is being washed off 
during later steps. By increasing the binding time, it is possible that more protein will bind to the column 
and therefore could be eluted later. 
4.2.1 Size-exclusion chromatography of dialysed sample 
Size-exclusion chromatography (SEC) of the haliotisin-like peptide that underwent dialysis did not result 
in significant peaks in the elution profile (Supplementary Figure 5.4), indicating that either the 
concentration of the sample was too low to induce a noticeable peak within the A280nm readings and 
hence no peak was visible on the elution profile, or the peptide present was not in a uniform conformation 
and was eluted over the entire time interval of the SEC. However, the sample still showed some 
antimicrobial functioning (Figure 3.13i), an indication that at least some of the haliotisin-like peptides that 
were present in the sample had folded correctly and were functionally active.  
4.2.2 FPLC purification and refolding 
To keep the peptide in a charged state so that electrostatic repulsion would stop the peptide from 
aggregating on the column (Bondos & Bicknell 2003), the pH of the denaturing buffer was lowered to only 
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6.7. This value was chosen as it remained one pH unit higher than the predicted isoelectric point (pI) of 
the peptide at 5.8.  
In the FPLC protein refolding and purification, a peak in the A280nm profile was present during the Triton 
wash of the samples (Figure 3.11 B), probably because Triton X-100 absorbs at a 275 nm which is close to 
the wavelength measured here for protein concentration. It is unlikely to represent any protein being 
eluted at this stage, regardless the fractions from this range were examined on an SDS-PAGE and found 
to contain no proteins. The fractions that did contain the haliotisin-like peptide were 21 and 22 which 
corresponded to the final peak in the elution profile shown in Figure 3.11C. This indicates that the peptide 
bound with a higher affinity to the resin than any other protein within the sample and shows that the 
peptide must contain the 6-His residues at the N-terminal end, and that only with an imidazole 
concentration over 100 mM was it able to elute out. Figure 3.12 shows that the protein eluted separated 
at two slightly different sizes in the SDS-PAGE. This could be due to limited proteolytic activity and could 
also explain why Figure 3.13 shows two zones of clearing for the active peptide. However, due to the low 
quality of the gel and the limited sample these possibilities could not be explored in this study. It is 
important to note that while this demonstrates the haliotisin-like peptide was appropriately purified using 
FPLC, it does not give any indication as to whether or not the peptide folded in the correct manner.  
4.2.3 Concentration of the haliotisin-like peptide 
Even after using the Amicon® Ultra, the concentration of the haliotisin-like peptide was still only between 
50 and 100 μg/ml. This may be because the starting culture for recombinant protein expression was only 
25 ml, whereas culture volumes of over a litre are usually utilised for the recombinant expression of 
proteins. Using a greater culture volume would increase the total number of E. coli cells present and able 
to produce the required peptide, resulting in more total peptide being produced. However, the present 
study remains a proof of concept that the haliotisin-like peptide from H. midae could be produced in the 
E. coli BL21 cells and be purified using nickel affinity chromatography.  
The concentration of the haliotisin-like peptide was calculated to be 8.35 nM when used for the activity 
screening, which is significantly less than the 10 μM concentrations used by Zhuang et al. (2015) for their 
radial diffusion assays. Although the concentration of the H. midae haliotisin-like peptide is closer to the 
300 – 1 000 nM concentration range that Zhuang et al. (2015) found to be the minimum inhibitory 
concentration (MIC) of the P3 peptide against B. subtilis, the concentration of the H. midae peptide is still 
almost a hundred-fold lower. Thus, a higher concentration of the peptide could lead to a more consistent 
result with regard to the activity assays.  
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4.3 Activity screening 
The correct folding of the haliotisin-like peptide post-FPLC refolding and purification was not examined in 
detail in this study. This could have been performed as previously described through size exclusion 
chromatography (SEC), or more accurately using circular dichroism (Clarke 2011) or X-ray crystallography 
(Kataoka & Goto 1996). However, these methods all require a high concentration of starting peptide and 
could therefore not be performed on the sample obtained in this study.  
Two of the qualitative radial diffusion assays demonstrated that the peptide was active as an antimicrobial 
peptide. Activity against E. coli (Figure 3.13i) and S. aureus (Figure 3.13ii) demonstrates that this peptide 
was able to inhibit the growth of both a Gram-negative and -positive bacterium. It also demonstrates that 
the regions of the H. midae haemocyanin analogous to the P3 and P4-P5 regions identified by Zhuang et 
al. (2015) exhibit a similar anti-proliferating activity. The primary issue was that the purified peptide was 
at a low concentration, which limited the choice of the available assays that could be performed. A higher 
concentration of peptide would have been optimal to determine the MIC of the peptide against specific 
bacterium and accurately determine the mode of action of inhibition. As the quantity of peptide was 
limited, the concentration of the bacterial cultures was adjusted to conclude an appropriate starting 
concentration at which the peptide could potentially inhibit E. coli and S. aureus.  
4.3.1 Growth-inhibition assay 
A significant decrease in growth was observed when a low starting concentration of the Gram-negative 
bacterium, E. coli, was incubated with approximately 1 μg of the haliotisin-like peptide (Figure 3.14). The 
Gram-positive bacterium, S. aureus, generally showed less growth in the presence of the peptide, but not 
to the same degree as E. coli, indicating that the peptide was better able to inhibit the growth of the Gram-
negative bacterium.  
The majority of bacterial organisms present in the marine environment are Gram-negative, except in the 
sediment (Gontang et al. 2007). As abalone inhabit primarily rocky shoreline regions, it is logical that the 
majority of the bacterial species that they would encounter are primarily Gram-negative and that their 
immune response would thus be better suited to preventing infection by members of the bacterial group 
that possess the thinner peptidoglycan layer.  
In this assay, the thicker peptidoglycan layer present in the cell wall of S. aureus may inhibit the action of 
haliotisin because the AMP has to first pass through the peptidoglycan layer in order to gain access to the 
phospholipid bilayer (Neelay et al. 2017). The variability in thickness between Gram-positive and -negative 
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bacteria may account for the differing efficacy of the AMP to inhibit the growth of the two strains. While 
visualising bacterial cells under transmission electron microscopy, Zhuang et al. (2015) observed that the 
Gram-negative strain they tested displayed cell wall abnormalities, appearing damaged and irregular 
when incubated with the P4 region of their haliotisin peptide. This indicates that the P4 region, which 
matches the full helix found in this study, was interacting with the cell wall and disturbing it in some way; 
the peptide may be effectively interacting with the E. coli cell walls and damaging them in order to cause 
cell leakage and bacterial death. The isolated peptide showed inconclusive results for V. anguillarum in 
this study. The strain of V. anguillarum was not uniform in its growth on the plate (Supplementary Figure 
5.6). This resulted in an inability to detect a zone of clearing with reference to the peptide. Due to the low 
quantity of peptide isolated the test could not be repeated. It is possible that because V. anguillarum was 
grown on tryptic soy agar, and the other bacteria were all grown on LA, that the additional sugar meant 
that the Vibrio were able to grow faster than the peptide was able to kill them. This can bee seen by a lack 
of a zone of clearing in the ampicillin control of V. anguillarum.  
Zhuang et al. (2015) determined that the N-terminal amino acids were required for the proper functioning 
of the P3 peptide against the Gram-positive strain included in their study and suggested that this may be 
caused by these groups interacting with a specific epitope present on the B. subtilis cell wall. If this N-
terminal portion is that important, it is possible that the his-tag present on the N-terminal end of the 
haliotisin-like peptide isolated in his study is inhibiting the antimicrobial action of the related P3 region 
when incubated with the two Gram-positive bacteria (B. subtilis and S. aureus), which could explain why 
the peptide showed lesser inhibitory effects against the S. aureus strain. To determine whether the his-tag 
blocks the activity of the P3 portion of the haliotisin-like peptide produced in the current study, the his-tag 
can be removed through treatment with a TEV protease which targets a site included in the pProEX vector.  
4.4 Conclusion 
In conclusion, functional units e–h of the H. midae haemocyanin were sequenced and showed phylogeny 
within the European and Australasian clade of Haliotidae evolution. The sequence showed the highest 
degree of similarity to the Australian black lip abalone, H. rubra. The isoform present in H. midae was the 
initial, older isoform 1 and no evidence of isoform 2 was found. The sequenced functional units contained 
FU-e, which has been shown to play a role in the immune response of invertebrates and this functional 
unit contained a region that matched the haliotisin peptide identified by Zhuang et al. (2015) with a high 
degree of similarity.  
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This haliotisin-like region was amplified from haemocyte DNA and cloned into an expression vector for 
recombinant expression in E. coli cells. The peptide obtained through recombinant expression was 
confirmed throughout several stages of this research project: the insert cloned into the vector was 
confirmed to have the correct DNA sequence; the size of the peptide produced was correct, as evidenced 
through SDS-PAGE analysis; the peptide contained the his-tag from the pProEX vector as evidenced 
through western blot analysis (Figure 3.8A) and because it bound to both the batch purification and the 
FPLC nickel-affinity column; and the peptide produced was bound by the anti-KLH antibody, indicating a 
region similar to that found within haemocyanin – which the E. coli host proteins lacked. Collectively, this 
information provides sufficient evidence to suggest that the produced peptide was the haliotisin-like 
peptide identified through sequence alignment.  
After purification, this peptide showed activity against both a Gram-negative and -positive bacterial strain. 
The peptide was able to significantly inhibit the growth of E. coli, demonstrating a greater anti-
proliferation activity against the Gram-negative bacterium. However, more testing must be conducted in 
order to gain further insight into this haliotisin-like peptide derived from the H. midae haemocyanin in 
terms of its regulation and function as a component of the abalone immune response.  
This research has provided a basis of knowledge around haemocyanin, and more specifically haliotisin, 
within the H. midae immune response. This acts as confirmation that the haemocyanin protein that was 
found to be upregulated in response to bacterial infection previously, is having an effect in the immune 
response of abalone. Therefore, this research acts as a starting point for further study on haemocyanin, 
and haliotisin, so that one day it could be used as a marker for the identification and diagnosis of disease 
within abalone. If haemocyanin is being upregulated when H. midae is under bacterial challenge and 
having an effect on the immune response as shown, then by testing for elevated levels of haemocyanin 
within abalone it would act as a proxy for bacterial infection. However, more research needs to be 
conducted in order to gain a complete picture and this study acts as the starting point for said research.  
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5. Appendix 
5.1 Supplementary data 
5.1.1 SDS-PAGE gel recipe 
In preparation for casting the electrophoresis gel a 4 X Tris·Cl SDS pH 8.8 (1.5 M Tris, 0.4% SDS) and a 4 X 
Tris·Cl SDS pH 6.8 (1.5 M Tris, 0.4% SDS) were made up and stored at 4°C. A 15% resolving gel was made 
up using 1 ml of acrylamide/bis-acrylamide 37:1 ratio (Merck) in a 1 X Tris·Cl SDS pH 8.8 solution made to 
a final volume of 5 ml. To initiate polymerisation, 50 μl of fresh ammonium persulfate (APS) and 5 μl of 
N, N, N’, N’- tetramethyl ethylenediamine (TEMED) was added. This solution was cast into secured 10.1 x 
7.3 cm glass plates, and 1 ml of isopropanol was added to ensure a smooth layer on the upper surface.  
A 4% stacking gel was made up in a similar fashion, using 0.25 ml of acrylamide/bis-acrylamide 37:1 ratio 
(Merck) in a 1 X Tris·Cl SDS pH 6.8 solution to a final volume of 2.5 ml. The isopropanol was thoroughly 
removed from the gel rigging after an hour, when the resolving gel had set. To initiate polymerisation, 
25 μl of fresh APS and 5 μl of TEMED was added to the stacking gel. The stacking gel was added above the 
resolving gel in the gel rigging. A comb was placed into the stacking gel to create appropriate spaces for 
sample loading. The stacking gel was allowed to set for one hour before being placed into the 
electrophoresis tank, the comb being removed, and the tank filled with 1 X running buffer (25 mM Tris, 
192 mM glycine, 0.1% SDS). 
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5.1.2 Supplementary figures 
A 
>Partial H. midae haemocyanin DNA sequence (FU-e,f,g and h) 
GTCAGAGCTTTGGAGGGAATGCAGAATGATCACTCCGCTGATGGATACCAAGCCATCGCTTCTTTCCATGCCCTGCCGCCACTC
TGCCCTAATCCAGCTGCAGCTCACCGTTTTGCTTGTTGTGTCCACGGTATGGCTACATTCCCCCAGTGGCACAGGCTGTACACT
GTACAGTTCCAGGATGCACTGAGAAGACATGGTTCACTTGTTGGTGTTCCGTACTGGGACTGGACGAAGCCAGTCGCCGAATT
ACCCAAGCTTCTTTCTTCGGAGACATTTCATGATCCAATCCACAATATTAATATTTCAAATCCATTCTTCCAAGCTGATATAGAAT
TCGAAGGAGCGGGCGTTCATACCGAGAGGCACATAAATGAAGATCGCCTGTTTCACAGTGGAGATCATGAGGGATACCATAA
CTGGTTCTTTGAGACTGTTCTCTTTGCTTTGGAACAGGAAGATTACTGCGATTTTGAAATACAGTTTGAGATAGCCCATAATGG
CATTCACACATGGCTTGGTGGAAACGCAGTACATGGCATGGGACACCTTCACTATGCTTCTTATGATCCAATCTTCTACGTCCAC
CATTCACAGACAGACAGAATATGGGCTATTTGGCAAGAGCTGCAGAAGTACAGGGGCCTATCTGGTTCAGAAGCAAACTGTG
CCATTGAACATATGAGAACACCTTTGAAGCCCTTCAGCTTTGGGCCACCTTACAATTTGAATCATCATACGCAAGAATTTTCAAA
GCCTGAGGACACTTTTGACTATAAGAAGTTTGGATACAGATATGATAGTCTGGAATTGGAGGGACGGTCAATTGCTCATCTTG
ATGAACTTATCAAGGAAAGACAGGAGCAAGACAGAACTTTTGCAGGGTTCCTTCTTAAAGGTTTTGGTACTTCCGCAACTGTGT
CATTCGAAATTTGCAGAGTTGATCACACCTGTGAAAAAGCCGGGTATTTCACTATTCTGGGAGGATCCGCAGAAATGCCATGG
GTGTTCGACAGGCTCTACAAGTACGACATTACTAAAACTCTCCACGATATGCACCTGAGGCCCGAGGATACCTTCTCTGTAAAA
GTAACTGTCACTTCTTACAATGGAACAGTACTCTCGGGAGACCTCATCCAGACACCGTCCATCATATTTGTACCTGGGCGCCAT
AAGCTAAATTCACGGAAACATGCACCTAACAAGATCCGCCATGAGTTAAGTAGCCTTAGTTCCCGTAACATAGCAAGCTTGAA
GGCTGCGTTGACAAGTCTTCAACATGATAGTGGAACTGATGGTTATCAAGCCACTGCTGCATTCCATGGCGTCCCTGCGCAGT
GCCACGATGCATCTGGACGTGAGATCGCTTGTTGCATCCATGGTATGGCGACATTCCCCGACTGGCACAGGTTGTACACCCTCC
AGTTGGAACAGGCCTTGAGCAGACATGGTTCCAGTGTTGCGGTGCCTTACTGGGATTGGACCAAGCCAATTACTGAACTACCA
CACCTTTTGACAGATGGAGAATATTACGATGTTTGGCAAAATGCCGTCATAACCAATCCATTTGCAAGAGGTTATGTGAAATTT
AAAGATGCATTCACAGTGAGAAATGTCCAGGAAGGTCTGTTCAAAATGTCAACTTTTGGAAAGCACTCACTTCTGTTTGACCAG
GCTTTGTTGGCTCTTGAACAAACTGACTACTGTGACTTCGAAGTTCAGTTTGAAGTGATGCACAACACGATCCACTATCTCGTTG
GAGGACGTCAAACGTACGCCTTCTCCTCTCTTGAGTATTCATCATACGATCCAATCTTCTTTATCCATCACTCATTTGTTGACAAA
ATATGGCCTGTATGGCAAGAACTGCAAAGCAGGAGACATCTACAGTATAAGGCAGCTGATTGTGCTGTGCGGCTAATGAGTA
AGGCAATGAGACCTTTCAACAAGGATTTCAACCACAACTCATTCACGAAGAAGCATGCAGTTCCAAATACAGTATTTGACTATG
AAGATCTTGGCTATAACTATGACAACCTTGAACTCAGTGGTTTGAACCTGAATGAAATCGAGGCGTTGATATCAAAACGAAAG
TCACATGCTAGAGTCTTTGCTGGTTTCCTGTTGTTTGGACTAGGAACCTCGGCTGATATACATCTGGACATTTGCAAGACATCC
GAAAACTGCCATCATGCTGGTGTGATCTTCATCCTGGGAGGTTCTGCAGAGATGCATTGGGCATACAACCGACTCTACAAGTA
TGATATTACAGAAGCACTGCATGAATTTGACATCAACCCTGAAGATGTTTTCCATGCTGATGAACCATTTTTCCTGAAGCTGTCT
GTGGTTGCTGTGGATGGGACTGTCATTCCATCGCCTCGCCTTCACCAGCCAACAATAATTTATGAACCAGGAGAAGGTCATCAT
GATGACCACGAGTCGGGAAGCATAGCAGGATCTGGTGTCCGCAAGGACGTGAACACCCTTACAAAAGCTGAGACTGACAACC
TGAGGGAAGCACTTCAAGGTGTAATGGACGACCATGGTCCCAATGGCTTTCAAGCCATTGCTGCTTTCCATGGAAAACCAGCT
TTGTGTCCCATGCCTGATGGTCACAACTACTCATGTTGCACTCATGGCATGGCTACCTTCCCACACTGGCATCGCCTCTACACGA
AGCACATGGAAGATGCATTGAAGGCTCACGGATCTCTCGTTGGCCTCCCCTACTGGGACTGGACTACTGCCTTTACCCATCTGC
CAACACTTGTCACCGACACCGAAAACAACCCTTTCAACCATGGCCACATTGAGTATCTCAATGTCGACACAACCCGTTCTCCCAG
AGACATGCTGTTCAACGACCCCGAGCACGGATCAGAGTCGTTCTTCTACAGACAAGTCCTTTTTGCTCTGGAGCAAACTGATTT
CTGCAAGTTCGAGGTTCAGTATGAGATAACCCACAATGCTATCCATTCCTGGACAGGTGGCCACAGTCCTTATGGTATGTCCAC
TCTCGACTTCACTGCCTACGATCCACTGTTCTGGCTACATCACTCCAACACGGATAGAATCTGGGCTATCTGGCAAGCTTTGCAA
GAATACAGAGGACTCCCATACAACCATGCCAATTGTGAGATCCAGGCAATGAAAACGCCCCTGAGGCCTTTCAGTGACGATAT
CAACCATAATCCAGTCACAAAGGCTAACTCAAAGCCGGTAGATGTGTTCGAGTATAATCGGTTAAGCTTCCAGTACGACACCCT
CATTTTCCATGGGTATAGTATTCCGGAACTTGATCACATGCTTGAAGAAAGGAAGAAGGAAGACAGAATATTTGCCGCCTTCCT
TCTCAGTGGAATCAAGCAAAGTGCTGATGTAGTTTTCGATGTATGCCAACCAGGTCACGAATGTGTGTTTGCAGGCACTTTTGC
GATCTTGGGAGGAGAGCTTGAAATGCCCTGGTCCTTTGACAGACTGTTCCGCTATGACATCACCAAAGTCATGAAACAGCTGC
ACCTGAGACACGATTCGGACTTTACGTTTAGGGTGAAGATTGTCGGCACTGACGAACACGAGCTTCCTTCTGACAGTTTCAAA
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GCACCAACTATTGAATTTGAACCAGGGGTACACGACGGAGAGAAACACGACGGTGGTCATCATGACGACAGACACTCAGATG
TCCTGATCAGAAAAGAAGTTGACTTCCTCTCCCTGCAGGAGGCCAATGCCATTAAGGATGCACTGTACAAGCTCCAGAATGAC
AACGGTAAAGGAGGCTTTGAGGCCATAGCTGGCTATCACGGGTATCCTAATATGTGCCCAGAAAAAGAGACCGACAAGTATC
CGTGCTGCGTCCATGAAATGCCTGTGTTCCCTCACTGGCATCGCCTGCATACCATTCAGATGGAGAGAGCTCTTAAAAACCATG
GTTCGCCGATGGGCATTCCTTATTGGGATTGGACAAAGAAGATGTCGAGTCTTCCAGCATTCTTTGCAGATTCCGGTAATGGCA
ACCCCTTCTACAAATATCATATAAGGGGTGTGCAACATGAAACAACCAGGGAAATTAATCCTAGTATCTTTAATCAGACCAAGT
TTGGTGAATATGATTACCTATACTACCTGACTCTGCAAGTCCTGGAAGAAAACTCATACTGCGACTTTGAGGTACAGTATGAGA
TCCTTCACAACGCCATCCATGCCTGGCTTGGAGGATCTGGAAAGTATTCAATGTCTACCCTTGAGTATTCAGCTTTTGACCCTGT
CTTCATGATTCATCACTCTAGTTTGGATAGAATCTGGATCCTTTGGCAGAAGTTGCAAAAGAGAAGAATGAAGCCTTACTACGC
AATAGACTGTGCTGGAGATAGACTAATGAAGTCCCCCTTGCATCCCTTTAACTACGAAACCGTCAATGAAGATGAGTTCACTCG
AATCAACTCTTACCCAAACATAGTGTTTGACCACTACAGGTTCAACTATGAATACGATAACTTGAGAGTCAGAGGTCATGACAT
ACATGAGCTTGAAGACGTACTTAAGGAATTAAGACACAAAGATCGCATATTTGCTGGTTTTGTTTTGTCGGGCTTACGGATATC
AGCTACAGTGAAAGTATTCATTCATTCGAAAAATGCAACAAGTCACGAAGAATATGC 
B 
>  Amino acid sequence of the H. midae carboxyl portion of the haemocyanin derived from the 
nucleotide sequence 
VRALEGMQNDHSADGYQAIASFHALPPLCPNPAAAHRFACCVHGMATFPQWHRLYTVQFQDALRRHGSLVGVPYWDWTKPVA
ELPKLLSSETFHDPIHNINISNPFFQADIEFEGAGVHTERHINEDRLFHSGDHEGYHNWFFETVLFALEQEDYCDFEIQFEIAHNGIHT
WLGGNAVHGMGHLHYASYDPIFYVHHSQTDRIWAIWQELQKYRGLSGSEANCAIEHMRTPLKPFSFGPPYNLNHHTQEFSKPEDT
FDYKKFGYRYDSLELEGRSIAHLDELIKERQEQDRTFAGFLLKGFGTSATVSFEICRVDHTCEKAGYFTILGGSAEMPWVFDRLYKYDIT
KTLHDMHLRPEDTFSVKVTVTSYNGTVLSGDLIQTPSIIFVPGRHKLNSRKHAPNKIRHELSSLSSRNIASLKAALTSLQHDSGTDGYQA
TAAFHGVPAQCHDASGREIACCIHGMATFPDWHRLYTLQLEQALSRHGSSVAVPYWDWTKPITELPHLLTDGEYYDVWQNAVITN
PFARGYVKFKDAFTVRNVQEGLFKMSTFGKHSLLFDQALLALEQTDYCDFEVQFEVMHNTIHYLVGGRQTYAFSSLEYSSYDPIFFIH
HSFVDKIWPVWQELQSRRHLQYKAADCAVRLMSKAMRPFNKDFNHNSFTKKHAVPNTVFDYEDLGYNYDNLELSGLNLNEIEALIS
KRKSHARVFAGFLLFGLGTSADIHLDICKTSENCHHAGVIFILGGSAEMHWAYNRLYKYDITEALHEFDINPEDVFHADEPFFLKLSVV
AVDGTVIPSPRLHQPTIIYEPGEGHHDDHESGSIAGSGVRKDVNTLTKAETDNLREALQGVMDDHGPNGFQAIAAFHGKPALCPM
PDGHNYSCCTHGMATFPHWHRLYTKHMEDALKAHGSLVGLPYWDWTTAFTHLPTLVTDTENNPFNHGHIEYLNVDTTRSPRDM
LFNDPEHGSESFFYRQVLFALEQTDFCKFEVQYEITHNAIHSWTGGHSPYGMSTLDFTAYDPLFWLHHSNTDRIWAIWQALQEYRG
LPYNHANCEIQAMKTPLRPFSDDINHNPVTKANSKPVDVFEYNRLSFQYDTLIFHGYSIPELDHMLEERKKEDRIFAAFLLSGIKQSAD
VVFDVCQPGHECVFAGTFAILGGELEMPWSFDRLFRYDITKVMKQLHLRHDSDFTFRVKIVGTDEHELPSDSFKAPTIEFEPGVHDG
EKHDGGHHDDRHSDVLIRKEVDFLSLQEANAIKDALYKLQNDNGKGGFEAIAGYHGYPNMCPEKETDKYPCCVHEMPVFPHWHR
LHTIQMERALKNHGSPMGIPYWDWTKKMSSLPAFFADSGNGNPFYKYHIRGVQHETTREINPSIFNQTKFGEYDYLYYLTLQVLEEN
SYCDFEVQYEILHNAIHAWLGGSGKYSMSTLEYSAFDPVFMIHHSSLDRIWILWQKLQKRRMKPYYAIDCAGDRLMKSPLHPFNYET
VNEDEFTRINSYPNIVFDHYRFNYEYDNLRVRGHDIHELEDVLKELRHKDRIFAGFVLSGLRISATVKVFIHSKNATSHEEY 
Supplementary Figure 5.1: A The partial DNA sequence of haemocyanin from H. midae obtained through this study. 
Sequencing primer regions highlighted in green. Cloning primer sites highlighted in grey. B Translated region of frame 
+1 with the haliotisin peptide region highlighted in blue.  
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Supplementary Figure 5.2: Full sequence obtained for carboxyl portion of the H. midae haemocyanin (H. midae sequence 
(FU-E, F, G, H)) aligned to other haemocyanin sequences from the NCBI database. The darker shaded regions indicate 
conserved nucleotide residues.  
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Supplementary Figure 5.3: Sequencing results of the cloned region of haliotisin within the pProEX vector. Yellow arrow indicates 
the open reading frame (ORF) for the multiple cloning site including the expected haliotisin peptide. The blue arrow indicates the 
6-his tag presented by the pProEX vector.  
 
 
Supplementary Figure 5.4: Profile of the size exclusion chromatography of dialysed 
samples containing haliotisin peptide.  
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Supplementary Figure 5.5: SDS-PAGE showing the deduced concentrations of the H. midae peptide samples 
compared to known amounts of BSA. The concentration of BSA ranged between 0.2 mg/ml to 2.4 mg/ml as 
indicated in the figure. The H. midae peptide was added undiluted (A), 1:2 dilution (B) and 1:5 dilution (C) 
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Supplementary Figure 5.6: Coomassie stained bacterial spread plates 
of the 4 different strains tested by the radial diffusion assay for 
susceptibility to the putative H. midae haliotisin-like peptide. E. coli on 
TSA (I) and LA (II), B. subtilis on TSA (III) and LA (IV), S. aureus on TSA (V) 
and LA (VI) and V. anguillarum on TSA (VII) and LA (VIII). Each strain was 
tested against the peptide solution purified by FPLC (A), 8M urea buffer 
(B), native buffer (C) and an equal concentration of ampicillin (D).  
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